<SEC-DOCUMENT>0001178913-23-000679.txt : 20230221
<SEC-HEADER>0001178913-23-000679.hdr.sgml : 20230221
<ACCEPTANCE-DATETIME>20230221070521
ACCESSION NUMBER:		0001178913-23-000679
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		15
CONFORMED PERIOD OF REPORT:	20230221
ITEM INFORMATION:		Other Events
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20230221
DATE AS OF CHANGE:		20230221

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Chemomab Therapeutics Ltd.
		CENTRAL INDEX KEY:			0001534248
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				813676773
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-38807
		FILM NUMBER:		23645228

	BUSINESS ADDRESS:	
		STREET 1:		KIRYAT ATIDIM, BUILDING 7
		CITY:			TEL AVIV
		STATE:			L3
		ZIP:			6158002
		BUSINESS PHONE:		972-77-331-0156

	MAIL ADDRESS:	
		STREET 1:		KIRYAT ATIDIM, BUILDING 7
		CITY:			TEL AVIV
		STATE:			L3
		ZIP:			6158002

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Anchiano Therapeutics Ltd.
		DATE OF NAME CHANGE:	20180906

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	BioCancell Ltd.
		DATE OF NAME CHANGE:	20111104
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>form8k.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<html xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:srt="http://fasb.org/srt/2022" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:us-gaap="http://fasb.org/us-gaap/2022" xmlns:dei="http://xbrl.sec.gov/dei/2022" xmlns:country="http://xbrl.sec.gov/country/2022" xmlns:currency="http://xbrl.sec.gov/currency/2022" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:naics="http://xbrl.sec.gov/naics/2022" xmlns:sic="http://xbrl.sec.gov/sic/2022" xmlns:stpr="http://xbrl.sec.gov/stpr/2022" xmlns:exch="http://xbrl.sec.gov/exch/2022" xmlns:cef="http://xbrl.sec.gov/cef/2022" xmlns:cmmb="http://chemomab.com/20230221" xmlns="http://www.w3.org/1999/xhtml">
  <head>
    <title></title>
    <!-- Licensed to: ZKG
         Document created using Broadridge PROfile 23.1.1.5115
         Copyright 1995 - 2023 Broadridge -->
    <meta http-equiv="Content-Type" content="text/html" />
</head>

<body style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left; color: #000000; background-color: #ffffff;">
<div id="DSPFiXBRLHidden" style="display: none;"><ix:header><ix:hidden><ix:nonNumeric name="dei:AmendmentFlag" id="Fact_c4648d413a80429490b83737684960a3" contextRef="c20230221to20230221" format="ixt:fixed-false">false</ix:nonNumeric><ix:nonNumeric name="dei:EntityTaxIdentificationNumber" id="Fact_827b499388894d2983d2699b4fac3458" contextRef="c20230221to20230221">00-0000000</ix:nonNumeric><ix:nonNumeric name="dei:EntityCentralIndexKey" id="Fact_bb5eac91d82c47d694f161e9a8eda0ed" contextRef="c20230221to20230221">0001534248</ix:nonNumeric><ix:nonNumeric name="dei:SecurityExchangeName" id="Fact_7800ee96276548b596341b580ba682e4" contextRef="c20230221to20230221_StatementClassOfStockAxis_OrdinarySharesNoParValuePerShareMember">NASDAQ</ix:nonNumeric><ix:nonNumeric name="dei:SecurityExchangeName" id="Fact_6d5d9dde38ce41a79ef18960f5e679b6" contextRef="c20230221to20230221_StatementClassOfStockAxis_AmericanDepositarySharesEachRepresentingTwenty20OrdinarySharesNoParValuePerShareMember">NASDAQ</ix:nonNumeric></ix:hidden><ix:references><link:schemaRef xlink:href="cmmb-20230221.xsd" xlink:type="simple"></link:schemaRef></ix:references><ix:resources><xbrli:context id="c20230221to20230221"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534248</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2023-02-21</xbrli:startDate><xbrli:endDate>2023-02-21</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20230221to20230221_StatementClassOfStockAxis_AmericanDepositarySharesEachRepresentingTwenty20OrdinarySharesNoParValuePerShareMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534248</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">cmmb:AmericanDepositarySharesEachRepresentingTwenty20OrdinarySharesNoParValuePerShareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-02-21</xbrli:startDate><xbrli:endDate>2023-02-21</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20230221to20230221_StatementClassOfStockAxis_OrdinarySharesNoParValuePerShareMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534248</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">cmmb:OrdinarySharesNoParValuePerShareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-02-21</xbrli:startDate><xbrli:endDate>2023-02-21</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div>

  <div><span style="font-family: 'Times New Roman',Times,serif; font-size: 10pt;"> </span></div>

  <div>
    <hr style="border: none; border-bottom: 1px solid black; border-top: 4px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;" />
    <div> <div><br /></div>

      <p style="font: 10pt 'Times New Roman',Times,serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center;"><b> UNITED STATES</b></p>
      <p style="font: 14pt 'Times New Roman',Times,serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center;"><b>SECURITIES AND EXCHANGE COMMISSION</b></p>
      <p style="font: 10pt 'Times New Roman',Times,serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center;"><b>WASHINGTON, D.C. 20549</b></p>
      <p style="font: 10pt 'Times New Roman',Times,serif; margin-top: 0pt; margin-bottom: 0pt;">&#160;&#160;</p>
      <p style="font: 14pt 'Times New Roman',Times,serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center;"><b>FORM <ix:nonNumeric name="dei:DocumentType" id="Fact_1e8d67a5e319479a96041d8c4f7e3915" contextRef="c20230221to20230221">8-K</ix:nonNumeric></b></p>
      <p style="font: 10pt 'Times New Roman',Times,serif; margin-top: 0pt; margin-bottom: 0pt;">&#160;</p>
      <p style="font: 10pt 'Times New Roman',Times,serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center;"><b>CURRENT REPORT</b></p>
      <p style="font: 10pt 'Times New Roman',Times,serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center;"><b>Pursuant to Section&#160;13 or 15(d)</b></p>
      <p style="font: 10pt 'Times New Roman',Times,serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center;"><b>of the Securities Exchange Act of 1934</b></p>
      <p style="font: 10pt 'Times New Roman',Times,serif; margin-top: 0pt; margin-bottom: 0pt;">&#160;</p>
      <p style="font: 10pt 'Times New Roman',Times,serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center;"><b>Date of Report (Date of earliest event reported): <ix:nonNumeric name="dei:DocumentPeriodEndDate" id="Fact_097c3bd6996d46e2bd4575c8433d9ffd" contextRef="c20230221to20230221" format="ixt:date-monthname-day-year-en">February 21, 2023</ix:nonNumeric></b></p>
      <p style="font: 10pt 'Times New Roman',Times,serif; margin-top: 0pt; margin-bottom: 0pt;">&#160;</p>
      <p style="font: 16pt 'Times New Roman',Times,serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center;"><b><ix:nonNumeric name="dei:EntityRegistrantName" id="Fact_54f7699f403b4b8da0f3061dbb621ab8" contextRef="c20230221to20230221">Chemomab Therapeutics Ltd.</ix:nonNumeric><br />
        </b></p>
      <p style="font: 10pt 'Times New Roman',Times,serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center;"><b>(Exact name of Registrant as Specified in Its Charter)</b></p>
      <p style="font: 10pt 'Times New Roman',Times,serif; margin: 0pt 0px;">&#160;</p>
      <table cellspacing="0" cellpadding="0" border="0" style="font: 10pt/normal Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; font-size-adjust: none; font-stretch: normal;">


  <tr style="vertical-align: top;">

    <td style="width: 33%; text-align: center; font-family: 'Times New Roman',Times,serif; font-size: 10pt; font-weight: bold;">State of <ix:nonNumeric name="dei:EntityIncorporationStateCountryCode" id="Fact_ed7f83e55f0a4b08beddae26671ea988" contextRef="c20230221to20230221" format="ixt-sec:edgarprovcountryen">Israel</ix:nonNumeric></td>

    <td style="width: 33%; text-align: center; font-family: 'Times New Roman',Times,serif; font-size: 10pt; font-weight: bold;"><ix:nonNumeric name="dei:EntityFileNumber" id="Fact_23f534d54203453daaea000a94b759db" contextRef="c20230221to20230221">001-38807</ix:nonNumeric><br />
            </td>

    <td style="width: 33%; text-align: center; font-family: 'Times New Roman',Times,serif; font-size: 10pt; font-weight: bold;"><span style="-sec-ix-hidden:Fact_827b499388894d2983d2699b4fac3458">81-3676773</span><br />
            </td>

  </tr>

  <tr style="vertical-align: top;">

    <td style="text-align: center; font-family: 'Times New Roman',Times,serif; font-size: 10pt; width: 33%;"><b>(State or Other Jurisdiction</b></td>

    <td style="text-align: center; font-family: 'Times New Roman',Times,serif; font-size: 10pt; width: 33%;"><b>(Commission</b></td>

    <td style="text-align: center; font-family: 'Times New Roman',Times,serif; font-size: 10pt; width: 33%;"><b>(IRS Employer</b></td>

  </tr>

  <tr style="vertical-align: top;">

    <td style="text-align: center; font-family: 'Times New Roman',Times,serif; font-size: 10pt; width: 33%;"><b>of Incorporation)</b></td>

    <td style="text-align: center; font-family: 'Times New Roman',Times,serif; font-size: 10pt; width: 33%;"><b>File Number)</b></td>

    <td style="text-align: center; font-family: 'Times New Roman',Times,serif; font-size: 10pt; width: 33%;"><b>Identification No.)</b></td>

  </tr>


</table>
      <p style="font: 10pt 'Times New Roman',Times,serif; margin: 0pt 0px;">&#160;</p>
      <table cellspacing="0" cellpadding="0" border="0" style="font: 10pt/normal Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; font-size-adjust: none; font-stretch: normal;">


  <tr>

    <td style="width: 50%; text-align: center; vertical-align: top; font-family: 'Times New Roman',Times,serif; font-size: 10pt;"><span style="font-weight: bold;"><ix:nonNumeric name="dei:EntityAddressAddressLine1" id="Fact_e24b9d3f80794d4685c212a8f19bc425" contextRef="c20230221to20230221">Kiryat Atidim, Building 7</ix:nonNumeric></span><br />
            </td>

    <td style="width: 50%; vertical-align: bottom; font-family: 'Times New Roman',Times,serif; font-size: 10pt;">&#160;</td>

  </tr>

  <tr>

    <td style="text-align: center; vertical-align: top; font-family: 'Times New Roman',Times,serif; font-size: 10pt; width: 50%;"><b><ix:nonNumeric name="dei:EntityAddressCityOrTown" id="Fact_4fa2b9620e824a57b1f54dd90922a682" contextRef="c20230221to20230221">Tel Aviv</ix:nonNumeric>,
                <ix:nonNumeric name="dei:EntityAddressCountry" id="Fact_b9d79dd8c8ac402da729318d023d8bec" contextRef="c20230221to20230221" format="ixt-sec:countrynameen">Israel</ix:nonNumeric></b></td>

    <td style="text-align: center; vertical-align: bottom; font-family: 'Times New Roman',Times,serif; font-size: 10pt; width: 50%;"><b><ix:nonNumeric name="dei:EntityAddressPostalZipCode" id="Fact_7d3c117f227b4ad7b829a6bd78c06980" contextRef="c20230221to20230221">6158002</ix:nonNumeric><br />
              </b></td>

  </tr>

  <tr>

    <td style="text-align: center; vertical-align: top; font-family: 'Times New Roman',Times,serif; font-size: 10pt; width: 50%;"><b>(Address of principal executive offices)</b></td>

    <td style="text-align: center; vertical-align: bottom; font-family: 'Times New Roman',Times,serif; font-size: 10pt; width: 50%;"><b>(Zip Code)</b></td>

  </tr>


</table>
      <p style="font: 10pt 'Times New Roman',Times,serif; margin: 0pt 0px;">&#160;</p>
      <p style="font: 10pt 'Times New Roman',Times,serif; margin: 0pt 0px; text-align: center;"><b>Registrant&#8217;s telephone number, including area code: +<ix:nonNumeric name="dei:CityAreaCode" id="Fact_056db533a90749b29f8b400205334538" contextRef="c20230221to20230221">972</ix:nonNumeric>-<ix:nonNumeric name="dei:LocalPhoneNumber" id="Fact_a465d30b3ba54a55af9eec32f997a7b4" contextRef="c20230221to20230221">77-331-0156</ix:nonNumeric></b></p>
      <p style="font: 10pt 'Times New Roman',Times,serif; margin: 0pt 0px;">&#160;</p>
      <p style="font: 10pt 'Times New Roman',Times,serif; margin: 0pt 0px; text-align: center;"><b>(Former name or former address, if changed since last report)</b></p>
      <p style="font: 10pt 'Times New Roman',Times,serif; margin: 0pt 0px;">&#160;</p>
      <p style="font: 10pt 'Times New Roman',Times,serif; margin: 0pt 0px;">Check the appropriate box below if the Form&#160;8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</p>
      <p style="font: 10pt 'Times New Roman',Times,serif; margin: 0pt 0px;">&#160;</p>
      <table cellspacing="0" cellpadding="0" style="font: 10pt/normal Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; font-size-adjust: none; font-stretch: normal;">


  <tr style="vertical-align: top;">

    <td style="width: 5%; text-align: left; font-family: 'Times New Roman',Times,serif; font-size: 10pt;"><ix:nonNumeric name="dei:WrittenCommunications" id="Fact_58591e2e1f2443529562a6b7d3838234" contextRef="c20230221to20230221" format="ixt-sec:boolballotbox">&#x2610;</ix:nonNumeric><br />
            </td>

    <td style="width: 95%; text-align: justify; font-family: 'Times New Roman',Times,serif; font-size: 10pt;">Written communications pursuant to Rule&#160;425 under the Securities Act (17 CFR 230.425)</td>

  </tr>

  <tr style="vertical-align: top;">

    <td style="text-align: left; font-family: 'Times New Roman',Times,serif; font-size: 10pt;">&#160;</td>

    <td style="text-align: justify; font-family: 'Times New Roman',Times,serif; font-size: 10pt;">&#160;</td>

  </tr>

  <tr style="vertical-align: top;">

    <td style="text-align: left; font-family: 'Times New Roman',Times,serif; font-size: 10pt;"><ix:nonNumeric name="dei:SolicitingMaterial" id="Fact_34813f63dc0844ef81c013044741f24c" contextRef="c20230221to20230221" format="ixt-sec:boolballotbox">&#x2610;</ix:nonNumeric><br />
            </td>

    <td style="text-align: justify; font-family: 'Times New Roman',Times,serif; font-size: 10pt;">Soliciting material pursuant to Rule&#160;14a-12 under the Exchange Act (17 CFR 240.14a-12)</td>

  </tr>

  <tr style="vertical-align: top;">

    <td style="text-align: left; font-family: 'Times New Roman',Times,serif; font-size: 10pt;">&#160;</td>

    <td style="text-align: justify; font-family: 'Times New Roman',Times,serif; font-size: 10pt;">&#160;</td>

  </tr>

  <tr style="vertical-align: top;">

    <td style="text-align: left; font-family: 'Times New Roman',Times,serif; font-size: 10pt;"><ix:nonNumeric name="dei:PreCommencementTenderOffer" id="Fact_c93b00f1407c48d2abcfa1faa8eb2967" contextRef="c20230221to20230221" format="ixt-sec:boolballotbox">&#x2610;</ix:nonNumeric><br />
            </td>

    <td style="text-align: justify; font-family: 'Times New Roman',Times,serif; font-size: 10pt;">Pre-commencement communications pursuant to Rule&#160;14d-2(b)&#160;under the Exchange Act (17 CFR 240.14d-2(b))</td>

  </tr>

  <tr style="vertical-align: top;">

    <td style="text-align: left; font-family: 'Times New Roman',Times,serif; font-size: 10pt;">&#160;</td>

    <td style="text-align: justify; font-family: 'Times New Roman',Times,serif; font-size: 10pt;">&#160;</td>

  </tr>

  <tr style="vertical-align: top;">

    <td style="text-align: left; font-family: 'Times New Roman',Times,serif; font-size: 10pt;"><ix:nonNumeric name="dei:PreCommencementIssuerTenderOffer" id="Fact_ee53ffb1d4404dd9bf8384d2237b75eb" contextRef="c20230221to20230221" format="ixt-sec:boolballotbox">&#x2610;</ix:nonNumeric><br />
            </td>

    <td style="text-align: justify; font-family: 'Times New Roman',Times,serif; font-size: 10pt;">Pre-commencement communications pursuant to Rule&#160;13e-4(c)&#160;under the Exchange Act (17 CFR 240.13e-4(c))</td>

  </tr>


</table>
      <p style="font: 10pt 'Times New Roman',Times,serif; margin: 0pt 0px; text-align: center;">&#160;</p>
      <p style="font: 10pt 'Times New Roman',Times,serif; margin: 0pt 0px; text-align: center;"><b>Securities registered pursuant to Section&#160;12(b)&#160;of the Act:</b></p>
      <p style="font: 10pt 'Times New Roman',Times,serif; margin: 0pt 0px;">&#160;</p>
      <table cellspacing="0" cellpadding="0" border="0" style="font: 10pt/normal Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; font-size-adjust: none; font-stretch: normal;">


  <tr style="vertical-align: bottom;">

    <td style="width: 49%; text-align: center; white-space: nowrap; font-family: 'Times New Roman',Times,serif; font-size: 10pt; border-bottom: 2px solid rgb(0, 0, 0);"><b>Title of each class</b></td>

    <td style="width: 1%; text-align: center; font-family: 'Times New Roman',Times,serif; font-size: 10pt; padding-bottom: 2px;">&#160;</td>

    <td style="width: 24%; text-align: center; font-family: 'Times New Roman',Times,serif; font-size: 10pt; border-bottom: 2px solid rgb(0, 0, 0);"><b>Trading<br />
                Symbol(s)</b></td>

    <td style="width: 1%; text-align: center; font-family: 'Times New Roman',Times,serif; font-size: 10pt; padding-bottom: 2px;">&#160;</td>

    <td style="width: 25%; text-align: center; font-family: 'Times New Roman',Times,serif; font-size: 10pt; border-bottom: 2px solid rgb(0, 0, 0);"><b>Name of each <br />
                exchange<br />
                on&#160;which&#160;registered</b></td>

  </tr>

  <tr>

    <td style="text-align: center; vertical-align: top; font-family: 'Times New Roman',Times,serif; font-size: 10pt; width: 49%; font-weight: bold;"><ix:nonNumeric name="dei:Security12bTitle" id="Fact_b123c56576e3485d98bde4754511ff63" contextRef="c20230221to20230221_StatementClassOfStockAxis_AmericanDepositarySharesEachRepresentingTwenty20OrdinarySharesNoParValuePerShareMember">American Depositary Shares, each representing twenty (20) ordinary shares, no par value per share</ix:nonNumeric><br />
            </td>

    <td style="text-align: center; vertical-align: bottom; font-family: 'Times New Roman',Times,serif; font-size: 10pt; width: 1%; font-weight: bold;">&#160;</td>

    <td style="text-align: center; vertical-align: top; font-family: 'Times New Roman',Times,serif; font-size: 10pt; width: 24%; font-weight: bold;"><ix:nonNumeric name="dei:TradingSymbol" id="Fact_efc8b1a62843452ea835025b22e31abb" contextRef="c20230221to20230221_StatementClassOfStockAxis_AmericanDepositarySharesEachRepresentingTwenty20OrdinarySharesNoParValuePerShareMember">CMMB</ix:nonNumeric><br />
            </td>

    <td style="text-align: center; vertical-align: bottom; font-family: 'Times New Roman',Times,serif; font-size: 10pt; width: 1%; font-weight: bold;">&#160;</td>

    <td style="text-align: center; vertical-align: top; font-family: 'Times New Roman',Times,serif; font-size: 10pt; width: 25%; font-weight: bold;"><span style="-sec-ix-hidden:Fact_6d5d9dde38ce41a79ef18960f5e679b6">Nasdaq Capital Market</span><br />
            </td>

  </tr>

  <tr>

    <td style="text-align: center; vertical-align: top; font-family: 'Times New Roman',Times,serif; font-size: 10pt; width: 49%; font-weight: bold;">&#160;</td>

    <td style="text-align: center; vertical-align: bottom; font-family: 'Times New Roman',Times,serif; font-size: 10pt; width: 1%; font-weight: bold;">&#160;</td>

    <td style="text-align: center; vertical-align: top; font-family: 'Times New Roman',Times,serif; font-size: 10pt; width: 24%; font-weight: bold;">&#160;</td>

    <td style="text-align: center; vertical-align: bottom; font-family: 'Times New Roman',Times,serif; font-size: 10pt; width: 1%; font-weight: bold;">&#160;</td>

    <td style="text-align: center; vertical-align: top; font-family: 'Times New Roman',Times,serif; font-size: 10pt; width: 25%; font-weight: bold;">&#160;</td>

  </tr>

  <tr>

    <td style="text-align: center; vertical-align: top; font-family: 'Times New Roman',Times,serif; font-size: 10pt; width: 49%; font-weight: bold;"><ix:nonNumeric name="dei:Security12bTitle" id="Fact_adcba5d2ba7c41fa96ede1c9ee9b9160" contextRef="c20230221to20230221_StatementClassOfStockAxis_OrdinarySharesNoParValuePerShareMember">Ordinary shares, no par value per share</ix:nonNumeric><br />
            </td>

    <td style="text-align: center; vertical-align: bottom; font-family: 'Times New Roman',Times,serif; font-size: 10pt; width: 1%; font-weight: bold;">&#160;</td>

    <td style="text-align: center; vertical-align: top; font-family: 'Times New Roman',Times,serif; font-size: 10pt; width: 24%; font-weight: bold;"><ix:nonNumeric name="dei:TradingSymbol" id="Fact_e57ed6f5b2144c9b95a26c319b8d02b2" contextRef="c20230221to20230221_StatementClassOfStockAxis_OrdinarySharesNoParValuePerShareMember">N/A</ix:nonNumeric></td>

    <td style="text-align: center; vertical-align: bottom; font-family: 'Times New Roman',Times,serif; font-size: 10pt; width: 1%; font-weight: bold;">&#160;</td>

    <td style="text-align: center; vertical-align: top; font-family: 'Times New Roman',Times,serif; font-size: 10pt; width: 25%; font-weight: bold;"><span style="-sec-ix-hidden:Fact_7800ee96276548b596341b580ba682e4">Nasdaq Capital Market</span>*</td>

  </tr>


</table>
      <p style="font: 10pt 'Times New Roman',Times,serif; margin: 0pt 0px;">&#160;</p>
      <p style="font: 10pt 'Times New Roman',Times,serif; margin: 0pt 0px;">* Not for trading; only in connection with the registration of American Depositary Shares.</p>
      <p style="font: 10pt 'Times New Roman',Times,serif; margin: 0pt 0px;">&#160;</p>
      <p style="font: 10pt 'Times New Roman',Times,serif; margin: 0pt 0px;">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule&#160;405 of the Securities Act of 1933 (&#167;&#160;230.405 of this chapter) or Rule&#160;12b-2 of the
        Securities Exchange Act of 1934 (&#167;&#160;240.12b-2 of this chapter).</p>
      <p style="font: 10pt 'Times New Roman',Times,serif; margin: 0pt 0px;">&#160;</p>
      <p style="font: 10pt 'Times New Roman',Times,serif; margin: 0pt 0px;">Emerging growth company&#160; <ix:nonNumeric name="dei:EntityEmergingGrowthCompany" id="Fact_dd30d57e27ef4063b7ff9d2b9c5d7da4" contextRef="c20230221to20230221" format="ixt-sec:boolballotbox">&#x2612;</ix:nonNumeric></p>
      <p style="font: 10pt 'Times New Roman',Times,serif; margin: 0pt 0px;">&#160;</p>
      <p style="font: 10pt 'Times New Roman',Times,serif; margin: 0pt 0px;">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial
        accounting standards provided pursuant to Section&#160;13(a)&#160;of the Exchange Act.&#160; <ix:nonNumeric name="dei:EntityExTransitionPeriod" id="Fact_4060debb196f400b9b60e23eaa2c782f" contextRef="c20230221to20230221" format="ixt-sec:boolballotbox">&#x2610;</ix:nonNumeric></p>
    </div>

    <div> <span style="font-family: 'Times New Roman',Times,serif; font-size: 10pt;"><br />
      </span></div>

    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <div style="font-family: 'Times New Roman',Times,serif; font-size: 10pt;"> <br />
    </div>

    <div style="font-family: 'Times New Roman',Times,serif; font-size: 10pt;">
      <div style="line-height: 1.25;">
        <div style="line-height: 1.25;"><br />
        </div>

      </div>

      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 6.66%; vertical-align: top;">
              <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">Item 8.01</div>
            </td>

    <td style="width: 93.34%; vertical-align: top;">
              <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">Other Events.</div>
            </td>

  </tr>


</table>
      <div style="line-height: 1.25;">
        <div style="line-height: 1.25;"><br />
        </div>

      </div>

      <div style="line-height: 1.25;">
        <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">
          <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">On February 21, 2023, Chemomab Therapeutics Ltd. issued a press release announcing FDA clearance of its
            investigational new drug application for phase 2 clinical trial of CM-101 in patients with systemic sclerosis.&#160;</div>

        </div>

        <div style="line-height: 1.25">&#160;</div>

        <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">A copy of the press release is attached hereto as Exhibit 99.1 and is incorporated herein by reference.</div>

        <div style="line-height: 1.25">&#160;</div>

      </div>

      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 6.66%; vertical-align: top;">
              <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">Item 9.01</div>
            </td>

    <td style="width: 93.34%; vertical-align: top;">
              <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">Financial Statements and Exhibits.</div>
            </td>

  </tr>


</table>
      <div style="line-height: 1.25;">
        <div style="line-height: 1.25;"><br />
        </div>

        <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">(d) Exhibits</div>

      </div>

      <div style="line-height: 1.25;">
        <div style="line-height: 1.25;"><br />
        </div>

      </div>

      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 8.66%; vertical-align: top; border-bottom: #000000 2px solid;">
              <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">Exhibit Number</div>
            </td>

    <td style="width: 0.6%; vertical-align: top;">
              <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
            </td>

    <td style="width: 90.74%; vertical-align: bottom; border-bottom: #000000 2px solid;">
              <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">Description</div>
            </td>

  </tr>

  <tr>

    <td style="width: 8.66%; vertical-align: top;">
              <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><a href="exhibit_99-1.htm">99.1</a></div>
            </td>

    <td style="width: 0.6%; vertical-align: top;"><br />
            </td>

    <td style="width: 90.74%; vertical-align: top;">
              <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><a href="exhibit_99-1.htm">Press release dated
                  February 21, 2023</a></div>
            </td>

  </tr>

  <tr>

    <td style="width: 8.66%; vertical-align: top;">
              <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">104</div>
            </td>

    <td style="width: 0.6%; vertical-align: top;">
              <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
            </td>

    <td style="width: 90.74%; vertical-align: top;">
              <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Cover Page Interactive Data File (embedded within the Inline XBRL document)</div>
            </td>

  </tr>


</table>
      <div style="line-height: 1.25;">
        <div style="line-height: 1.25;"><br />
        </div>

        <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
          <div class="BRPFPageBreak" style="page-break-after: always;">
            <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" /></div>

        </div>

        <div style="line-height: 1.25">&#160;<br />
        </div>

        <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its
          behalf by the undersigned hereunto duly authorized.</div>

        <div style="line-height: 1.25">&#160;</div>

      </div>

      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 49.77%; vertical-align: bottom;">
              <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
            </td>

    <td colspan="2" style="width: 30.51%; vertical-align: bottom;">
              <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">CHEMOMAB THERAPEUTICS LTD.</div>
            </td>

    <td style="width: 19.72%; vertical-align: bottom;">
              <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
            </td>

  </tr>

  <tr>

    <td style="width: 49.77%; vertical-align: middle;">
              <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
            </td>

    <td style="width: 3.61%; vertical-align: middle;">
              <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
            </td>

    <td style="width: 26.9%; vertical-align: middle;">
              <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
            </td>

    <td style="width: 19.72%; vertical-align: middle;">
              <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
            </td>

  </tr>

  <tr>

    <td style="width: 49.77%; vertical-align: top;">
              <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><span style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-weight: bold;">Date:&#160;</span>February 21, 2023</div>
            </td>

    <td style="width: 3.61%; vertical-align: top;">
              <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">By:</div>
            </td>

    <td style="width: 26.9%; vertical-align: top; border-bottom: #000000 2px solid;">
              <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><span style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-weight: bold;">/s/&#160;</span>Donald Marvin</div>
            </td>

    <td style="width: 19.72%; vertical-align: middle;">
              <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
            </td>

  </tr>

  <tr>

    <td style="width: 49.77%; vertical-align: bottom;">
              <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
            </td>

    <td style="width: 3.61%; vertical-align: bottom;">
              <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
            </td>

    <td style="width: 26.9%; vertical-align: bottom;">
              <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Name: Donald Marvin</div>
            </td>

    <td style="width: 19.72%; vertical-align: bottom;">
              <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
            </td>

  </tr>

  <tr>

    <td style="width: 49.77%; vertical-align: bottom;">
              <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
            </td>

    <td style="width: 3.61%; vertical-align: bottom;">
              <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
            </td>

    <td style="width: 26.9%; vertical-align: bottom;">
              <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Title: Executive V.P., Chief Financial Officer</div>
              <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">and Chief Operating Officer</div>
            </td>

    <td style="width: 19.72%; vertical-align: middle;">&#160;</td>

  </tr>


</table>
      <div style="line-height: 1.25;"><br />
      </div>

    </div>

    <div style="font-family: 'Times New Roman',Times,serif; font-size: 10pt;"><br />
    </div>

    <div>
      <hr style="border: none; border-bottom: 4px solid black; border-top: 1px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;" /></div>

  </div>

  <div><span style="font-family: 'Times New Roman',Times,serif; font-size: 10pt;"> </span></div>

</body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>exhibit_99-1.htm
<DESCRIPTION>EXHIBIT 99.1
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: Z-K Global
         Document created using Broadridge PROfile 23.1.1.5115
         Copyright 1995 - 2023 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left; color: #000000;">
  <div>
    <hr align="center" style="border: none; border-bottom: 1px solid black; border-top: 4px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;">
    <div> <br>
    </div>
    <div style="text-align: right;"><u><font style="font-weight: bold;">Exhibit 99.1</font></u><br>
    </div>
    <div>
      <div class="BRPFPageHeader">
        <div style="line-height: 1.25; text-align: left;"><br>
        </div>
      </div>
      <div style="text-align: left; line-height: 1.25; font-weight: bold;"> <img width="209" border="0" height="59" src="image00002.jpg"></div>
      <div style="text-align: center; line-height: 1.25; font-weight: bold; background-color: rgb(255, 255, 255); color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif; font-size: 12pt; font-style: normal; font-variant: normal; text-transform: none;"> <br>
      </div>
      <div style="text-align: center; line-height: 1.25; font-weight: bold; background-color: rgb(255, 255, 255); color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif; font-size: 12pt; font-style: normal; font-variant: normal; text-transform: none;">Chemomab Announces FDA Clearance of Investigational New Drug Application for </div>
      <font style="background-color: rgb(255, 255, 255); font-weight: bold; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif; font-size: 12pt; font-style: normal; font-variant: normal; text-transform: none;"> </font>
      <div style="text-align: center; line-height: 1.25; font-weight: bold; background-color: rgb(255, 255, 255); color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif; font-size: 12pt; font-style: normal; font-variant: normal; text-transform: none;">Phase 2 Clinical Trial of CM-101 in Patients with Systemic Sclerosis</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="line-height: 1.25;">
        <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman',Times,serif; font-style: italic;">&#8212;ABATE Phase 2 Trial Aims to Further Assess Safety and Establish Biological and Clinical <br>
        </div>
        <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman',Times,serif; font-style: italic;">Proof-of-Concept for CM-101 as a Potential Treatment for Patients with Systemic Sclerosis&#8212;</div>
      </div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="line-height: 1.25;"><font style="font-weight: bold;">TEL AVIV, Israel, February 21, 2023 </font>-- Chemomab Therapeutics, Ltd. (Nasdaq: CMMB) (Chemomab), a clinical-stage biotechnology company focused on the discovery and development of
        innovative therapeutics for fibro-inflammatory diseases with high unmet need, today announced U.S. Food and Drug Administration (FDA) clearance of the company&#8217;s Investigational New Drug (IND) Application to evaluate CM-101 in a Phase 2 trial in
        adults with systemic sclerosis (SSc).</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="line-height: 1.25;">
        <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">CM-101 is a first-in-class monoclonal antibody designed to interfere with key biological pathways associated with SSc and other serious
          fibro-inflammatory diseases. In preclinical studies, CM-101 reduced inflammatory and fibrotic injury to the lung, skin and vasculature&#8212;organ systems often affected in SSc patients. In early clinical trials, CM-101 was well-tolerated, reducing
          fibrogenesis-related biomarkers and demonstrating anti-inflammatory effects in patients with severe lung inflammation, non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH). CM-101 has been granted Orphan Drug
          designation by the FDA for SSc and for primary sclerosing cholangitis (PSC), a rare liver disease. The CM-101 Phase 2 SPRING trial in PSC patients is currently ongoing.</div>
      </div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="line-height: 1.25;">Matt Frankel, MD, Chief Medical Officer of Chemomab, said, &#8220;Achieving FDA clearance to initiate our Phase 2 systemic sclerosis trial is an important milestone for Chemomab. We are encouraged by the results of recent
        clinical studies of CM-101 in COVID patients with SSc-like acute lung injury and in NASH patients, which showed consistent trends in reducing multiple biomarkers associated with fibro-inflammatory disease. We believe that CM-101 has the potential
        to become the first disease-modifying treatment for this debilitating condition that is thought to be the most lethal of the systemic rheumatic disorders. We look forward to initiating patient enrollment in the first half of this year.<font style="font-style: italic;">&#8221;</font></div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="line-height: 1.25;">Francesco Del Galdo, MD, PhD, Professor of Experimental Medicine at the University of Leeds in the U.K. and Head of the Scleroderma Programme at the Leeds Institute of Rheumatic and Musculoskeletal Medicine, is the
        Principal Investigator of the Chemomab systemic sclerosis trial.</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="line-height: 1.25;">Professor Del Galdo noted, <font style="font-style: italic;">&#8220;</font>Preclinical studies conducted by me and my colleagues show that CCL24, the disease target of CM-101, appears to be a key driver of the immune-driven
        fibrosis affecting tissues including the lung, skin and blood vessels that are key aspects of SSc pathology. Our patients and we, as their physicians, urgently need an effective therapy able to treat the multiple manifestations of scleroderma. I
        welcome the opportunity to help launch and coordinate this innovative clinical trial for patients with SSc in the U.S., Europe and Israel, scheduled to open later this year.&#8221;</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="line-height: 1.25; font-weight: bold;">About the CM-101 Phase 2 Systemic Sclerosis Study&#9472;the ABATE Trial</div>
      <div style="line-height: 1.25;">The ABATE trial (a Phase 2, multicenter, randomized, double-blind, proof-of-biology study to evaluate the S<font style="font-weight: bold;">A</font>fety, Tolera<font style="font-weight: bold;">B</font>ility, and <font style="font-weight: bold;">A</font>ctivity of CM-101 in Patients with Sys<font style="font-weight: bold;">TE</font>mic Sclerosis) will enroll 45 patients with clinically active dermatologic, vascular or pulmonary SSc. The study population is
        expected to be roughly split between patients with diffuse cutaneous SSc and patients with limited SSc. The trial is designed to further assess safety and establish biological and clinical proof-of-concept for CM-101 as a potential treatment for
        patients with SSc. The primary outcome measure is safety. Secondary endpoints include multiple serum-based biological markers and a variety of exploratory biological and clinical outcomes, including the American College of Rheumatology Composite
        Response Index in Systemic Sclerosis (ACR-CRISS) score and its revisions (rCRISS). The trial includes a 24-week double blind period during which active treatment patients will receive 10 mg/kg of CM-101 by intravenous infusion every three weeks,
        followed by a 24-week open label extension, where all patients will receive a 10 mg/kg dose. The trial also includes multiple clinical assessments of the skin, vasculature and pulmonary function. It is expected to generate additional information
        about disease mechanisms, provide data relevant to future patient stratification strategies and inform the selection of appropriate endpoints for future studies. A top-line data read-out is planned for the second half of 2024.</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      <div style="line-height: 1.25; font-weight: bold;">About Systemic Sclerosis</div>
      <div style="line-height: 1.25;">Systemic sclerosis, also known as scleroderma, is a rare autoimmune rheumatic disease characterized by fibrosis and inflammation of the skin, joints and internal organs, as well as vascular abnormalities. It
        predominantly affects women and is typically diagnosed when patients are between 30 and 50 years old. It is considered the most lethal of the systemic rheumatic diseases with a median survival of only 10 years. There is&#160;no approved
        disease-modifying drug for the disease. Current estimates from the Scleroderma Foundation suggest there are approximately 100,000 systemic sclerosis patients in the U.S.</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="line-height: 1.25; font-weight: bold;">About Chemomab Therapeutics</div>
      <div style="line-height: 1.25;">Chemomab is a clinical stage biotechnology company focusing on the discovery and development of innovative therapeutics for fibrotic and inflammatory diseases with high unmet need. Extensive preclinical data showing
        the unique and pivotal role of the soluble protein CCL24 in promoting fibrosis and inflammation led Chemomab to develop CM-101, a monoclonal antibody designed to bind and block CCL24 activity. CM-101 has demonstrated the potential to treat multiple
        severe and life-threatening fibrotic and inflammatory diseases. A Phase 2 liver fibrosis biomarker study in NASH patients was recently completed and a Phase 2 trial in primary sclerosing cholangitis patients is ongoing. Chemomab expects to begin
        enrolling patients in a Phase 2 trial in systemic sclerosis in the first half of 2023. For more information on Chemomab, visit <u>chemomab.com</u>.</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="line-height: 1.25;">
        <div style="line-height: 1.25; font-weight: bold;">Forward Looking Statements</div>
      </div>
      <div style="line-height: 1.25;">This press release contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act. These forward-looking statements include, among other things, statements regarding the
        clinical development pathway for CM-101 and the potential for CM-101 to treat SSc; risks associated with data interpretation, whether the regulatory authority will agree with our interpretation, and whether earlier preclinical and/or clinical data
        are predictive of the results of future trials or studies; risks concerning the future operations of Chemomab and its ability to successfully initiate and complete clinical trials and achieve regulatory milestones; and the commercial potential and
        potential benefits of any product candidates. Any statements contained in this communication that are not statements of historical fact may be deemed to be forward-looking statements. Because such statements deal with future events and are based on
        Chemomab&#8217;s current expectations, they are subject to various risks and uncertainties and actual results, performance or achievements of Chemomab could differ materially from those described in or implied by the statements in this press release,
        including: risks related to Chemomab&#8217;s ability to effectively implement its clinical strategy and its ability to achieve the anticipated results; the uncertain and time-consuming regulatory approval process; risks related to Chemomab&#8217;s ability to
        correctly manage its operating expenses and its expenses; Chemomab&#8217;s plans to commercialize its product candidates; Chemomab&#8217;s ability to protect its intellectual property position; and the requirement for additional capital to continue to advance
        these product candidates, which may not be available on favorable terms or at all. Additional risks and uncertainties relating to Chemomab&#8217;s and its business can be found under the caption &#8220;Risk Factors&#8221; and elsewhere in Chemomab&#8217;s filings with the
        SEC. Chemomab expressly disclaims any obligation or undertaking to release publicly any updates or revisions to any forward-looking statements contained herein, except to the extent required by applicable law.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="line-height: 1.25;">
        <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman',Times,serif; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);" id="z1cbadc7097924a23935ef09ea4128352">

            <tr>
              <td style="width: 30%; vertical-align: top;">
                <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-weight: bold;">Contacts:</div>
              </td>
              <td style="width: 70%; vertical-align: top;">&#160;</td>
            </tr>
            <tr>
              <td rowspan="1" style="width: 30%; vertical-align: top;">&#160;</td>
              <td rowspan="1" style="width: 70%; vertical-align: top;">&#160;</td>
            </tr>
            <tr>
              <td style="width: 30%; vertical-align: top;">
                <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-weight: bold;">Media:</div>
              </td>
              <td style="width: 70%; vertical-align: top;">
                <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-weight: bold;">Investor Relations:</div>
              </td>
            </tr>
            <tr>
              <td style="width: 30%; vertical-align: top;">
                <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Barbara Lindheim</div>
              </td>
              <td style="width: 70%; vertical-align: top;">
                <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Irina Koffler</div>
              </td>
            </tr>
            <tr>
              <td style="width: 30%; vertical-align: top;">
                <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Chemomab Therapeutics</div>
              </td>
              <td style="width: 70%; vertical-align: top;">
                <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">LifeSci Advisors, LLC</div>
              </td>
            </tr>
            <tr>
              <td style="width: 30%; vertical-align: top;">
                <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Consulting Vice President</div>
              </td>
              <td style="width: 70%; vertical-align: top; font-weight: normal;">
                <div style="line-height: 1.25;">Phone: +1-917-734-7387</div>
              </td>
            </tr>
            <tr>
              <td style="width: 30%; vertical-align: top;">Investor &amp; Public Relations,</td>
              <td style="width: 70%; vertical-align: top;">
                <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;"><u>ir@chemomab.com</u></div>
              </td>
            </tr>
            <tr>
              <td style="width: 30%; vertical-align: top;">
                <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Strategic Communications</div>
              </td>
              <td style="width: 70%; vertical-align: top;">&#160;</td>
            </tr>
            <tr>
              <td style="width: 30%; vertical-align: top;">
                <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">
                  <div style="line-height: 1.25;">Phone: +1-917-355-9234</div>
                </div>
              </td>
              <td style="width: 70%; vertical-align: top;">
                <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;"><br>
                </div>
              </td>
            </tr>
            <tr>
              <td style="width: 30%; vertical-align: top;">
                <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;"><u>barbara@chemomab.com</u></div>
              </td>
              <td style="width: 70%; vertical-align: top;">&#160;</td>
            </tr>

        </table>
      </div>
      <div style="line-height: 1.25"> <br>
      </div>
      <div style="line-height: 1.25">
        <hr align="center" style="border: none; border-bottom: 4px solid black; border-top: 1px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;"></div>
      <br>
    </div>
  </div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>3
<FILENAME>cmmb-20230221.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!--Generated by Broadridge PROfile 23.1.1.5115 Broadridge-->
<xs:schema targetNamespace="http://chemomab.com/20230221" elementFormDefault="qualified" xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:cmmb="http://chemomab.com/20230221" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:us-types="http://fasb.org/us-types/2022" xmlns:srt-types="http://fasb.org/srt-types/2022" xmlns:dei="http://xbrl.sec.gov/dei/2022" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21">
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xlink:type="simple" xlink:href="cmmb-20230221_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
      <link:linkbaseRef xlink:type="simple" xlink:href="cmmb-20230221_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
      <link:linkbaseRef xlink:type="simple" xlink:href="cmmb-20230221_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
      <link:roleType roleURI="http://chemomab.com/role/DocumentAndEntityInformation" id="DocumentAndEntityInformation">
        <link:definition>000100 - Document - Document and Entity Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:import namespace="http://fasb.org/us-gaap/2022" schemaLocation="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/dei/2022" schemaLocation="https://xbrl.sec.gov/dei/2022/dei-2022.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/country/2022" schemaLocation="https://xbrl.sec.gov/country/2022/country-2022.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/currency/2022" schemaLocation="https://xbrl.sec.gov/currency/2022/currency-2022.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/exch/2022" schemaLocation="https://xbrl.sec.gov/exch/2022/exch-2022.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/naics/2022" schemaLocation="https://xbrl.sec.gov/naics/2022/naics-2022.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/sic/2022" schemaLocation="https://xbrl.sec.gov/sic/2022/sic-2022.xsd" />
  <xs:import namespace="http://www.xbrl.org/2009/role/negated" schemaLocation="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd" />
  <xs:import namespace="http://www.xbrl.org/2009/role/net" schemaLocation="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/stpr/2022" schemaLocation="https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd" />
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
  <xs:import namespace="http://www.xbrl.org/2004/ref" schemaLocation="http://www.xbrl.org/2004/ref-2004-08-10.xsd" />
  <xs:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" />
  <xs:import namespace="http://fasb.org/us-types/2022" schemaLocation="https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd" />
  <xs:import namespace="http://www.xbrl.org/2009/arcrole/fact-explanatoryFact" schemaLocation="http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd" />
  <xs:import namespace="http://fasb.org/srt/2022" schemaLocation="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd" />
  <xs:import namespace="http://fasb.org/srt-types/2022" schemaLocation="https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd" />
  <xs:import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd" />
  <xs:element name="AmericanDepositarySharesEachRepresentingTwenty20OrdinarySharesNoParValuePerShareMember" id="cmmb_AmericanDepositarySharesEachRepresentingTwenty20OrdinarySharesNoParValuePerShareMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="OrdinarySharesNoParValuePerShareMember" id="cmmb_OrdinarySharesNoParValuePerShareMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>4
<FILENAME>cmmb-20230221_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!--Generated by Broadridge PROfile 23.1.1.5115 Broadridge-->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:t1="http://xbrl.org/2005/xbrldt">
  <link:roleRef roleURI="http://chemomab.com/role/DocumentAndEntityInformation" xlink:type="simple" xlink:href="cmmb-20230221.xsd#DocumentAndEntityInformation" />
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" />
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" />
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" />
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" />
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" />
  <link:definitionLink xlink:type="extended" xlink:role="http://chemomab.com/role/DocumentAndEntityInformation">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityListingsLineItems" xlink:label="EntityListingsLineItems" xlink:title="EntityListingsLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType" xlink:label="DocumentType" xlink:title="DocumentType" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="DocumentType" xlink:title="definition: EntityListingsLineItems to DocumentType" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag" xlink:label="AmendmentFlag" xlink:title="AmendmentFlag" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="AmendmentFlag" xlink:title="definition: EntityListingsLineItems to AmendmentFlag" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate" xlink:label="DocumentPeriodEndDate" xlink:title="DocumentPeriodEndDate" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="DocumentPeriodEndDate" xlink:title="definition: EntityListingsLineItems to DocumentPeriodEndDate" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName" xlink:label="EntityRegistrantName" xlink:title="EntityRegistrantName" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="EntityRegistrantName" xlink:title="definition: EntityListingsLineItems to EntityRegistrantName" order="4.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="EntityIncorporationStateCountryCode" xlink:title="EntityIncorporationStateCountryCode" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="EntityIncorporationStateCountryCode" xlink:title="definition: EntityListingsLineItems to EntityIncorporationStateCountryCode" order="5.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber" xlink:label="EntityFileNumber" xlink:title="EntityFileNumber" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="EntityFileNumber" xlink:title="definition: EntityListingsLineItems to EntityFileNumber" order="6.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber" xlink:label="EntityTaxIdentificationNumber" xlink:title="EntityTaxIdentificationNumber" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="EntityTaxIdentificationNumber" xlink:title="definition: EntityListingsLineItems to EntityTaxIdentificationNumber" order="7.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1" xlink:label="EntityAddressAddressLine1" xlink:title="EntityAddressAddressLine1" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="EntityAddressAddressLine1" xlink:title="definition: EntityListingsLineItems to EntityAddressAddressLine1" order="8.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine2" xlink:label="EntityAddressAddressLine2" xlink:title="EntityAddressAddressLine2" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="EntityAddressAddressLine2" xlink:title="definition: EntityListingsLineItems to EntityAddressAddressLine2" order="9.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine3" xlink:label="EntityAddressAddressLine3" xlink:title="EntityAddressAddressLine3" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="EntityAddressAddressLine3" xlink:title="definition: EntityListingsLineItems to EntityAddressAddressLine3" order="10.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown" xlink:label="EntityAddressCityOrTown" xlink:title="EntityAddressCityOrTown" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="EntityAddressCityOrTown" xlink:title="definition: EntityListingsLineItems to EntityAddressCityOrTown" order="11.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince" xlink:label="EntityAddressStateOrProvince" xlink:title="EntityAddressStateOrProvince" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="EntityAddressStateOrProvince" xlink:title="definition: EntityListingsLineItems to EntityAddressStateOrProvince" order="12.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCountry" xlink:label="EntityAddressCountry" xlink:title="EntityAddressCountry" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="EntityAddressCountry" xlink:title="definition: EntityListingsLineItems to EntityAddressCountry" order="13.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode" xlink:label="EntityAddressPostalZipCode" xlink:title="EntityAddressPostalZipCode" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="EntityAddressPostalZipCode" xlink:title="definition: EntityListingsLineItems to EntityAddressPostalZipCode" order="14.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode" xlink:label="CityAreaCode" xlink:title="CityAreaCode" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="CityAreaCode" xlink:title="definition: EntityListingsLineItems to CityAreaCode" order="15.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber" xlink:label="LocalPhoneNumber" xlink:title="LocalPhoneNumber" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="LocalPhoneNumber" xlink:title="definition: EntityListingsLineItems to LocalPhoneNumber" order="16.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_WrittenCommunications" xlink:label="WrittenCommunications" xlink:title="WrittenCommunications" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="WrittenCommunications" xlink:title="definition: EntityListingsLineItems to WrittenCommunications" order="17.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SolicitingMaterial" xlink:label="SolicitingMaterial" xlink:title="SolicitingMaterial" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="SolicitingMaterial" xlink:title="definition: EntityListingsLineItems to SolicitingMaterial" order="18.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementTenderOffer" xlink:label="PreCommencementTenderOffer" xlink:title="PreCommencementTenderOffer" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="PreCommencementTenderOffer" xlink:title="definition: EntityListingsLineItems to PreCommencementTenderOffer" order="19.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="PreCommencementIssuerTenderOffer" xlink:title="PreCommencementIssuerTenderOffer" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="PreCommencementIssuerTenderOffer" xlink:title="definition: EntityListingsLineItems to PreCommencementIssuerTenderOffer" order="20.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_NoTradingSymbolFlag" xlink:label="NoTradingSymbolFlag" xlink:title="NoTradingSymbolFlag" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="NoTradingSymbolFlag" xlink:title="definition: EntityListingsLineItems to NoTradingSymbolFlag" order="21.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany" xlink:label="EntityEmergingGrowthCompany" xlink:title="EntityEmergingGrowthCompany" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="EntityEmergingGrowthCompany" xlink:title="definition: EntityListingsLineItems to EntityEmergingGrowthCompany" order="22.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityExTransitionPeriod" xlink:label="EntityExTransitionPeriod" xlink:title="EntityExTransitionPeriod" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="EntityExTransitionPeriod" xlink:title="definition: EntityListingsLineItems to EntityExTransitionPeriod" order="23.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalYearFocus" xlink:label="DocumentFiscalYearFocus" xlink:title="DocumentFiscalYearFocus" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="DocumentFiscalYearFocus" xlink:title="definition: EntityListingsLineItems to DocumentFiscalYearFocus" order="24.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="DocumentFiscalPeriodFocus" xlink:title="DocumentFiscalPeriodFocus" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="DocumentFiscalPeriodFocus" xlink:title="definition: EntityListingsLineItems to DocumentFiscalPeriodFocus" order="25.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey" xlink:label="EntityCentralIndexKey" xlink:title="EntityCentralIndexKey" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="EntityCentralIndexKey" xlink:title="definition: EntityListingsLineItems to EntityCentralIndexKey" order="26.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle" xlink:label="Security12bTitle" xlink:title="Security12bTitle" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="Security12bTitle" xlink:title="definition: EntityListingsLineItems to Security12bTitle" order="27.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol" xlink:label="TradingSymbol" xlink:title="TradingSymbol" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="TradingSymbol" xlink:title="definition: EntityListingsLineItems to TradingSymbol" order="28.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName" xlink:label="SecurityExchangeName" xlink:title="SecurityExchangeName" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="SecurityExchangeName" xlink:title="definition: EntityListingsLineItems to SecurityExchangeName" order="29.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityListingsTable" xlink:label="EntityListingsTable" xlink:title="EntityListingsTable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="EntityListingsLineItems" xlink:to="EntityListingsTable" xlink:title="definition: EntityListingsLineItems to EntityListingsTable" order="30.0" t1:closed="true" t1:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="StatementClassOfStockAxis" xlink:title="StatementClassOfStockAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="EntityListingsTable" xlink:to="StatementClassOfStockAxis" xlink:title="definition: EntityListingsTable to StatementClassOfStockAxis" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="ClassOfStockDomain" xlink:title="ClassOfStockDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="StatementClassOfStockAxis" xlink:to="ClassOfStockDomain" xlink:title="definition: StatementClassOfStockAxis to ClassOfStockDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="ClassOfStockDomain_2" xlink:title="ClassOfStockDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="StatementClassOfStockAxis" xlink:to="ClassOfStockDomain_2" xlink:title="definition: StatementClassOfStockAxis to ClassOfStockDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="cmmb-20230221.xsd#cmmb_AmericanDepositarySharesEachRepresentingTwenty20OrdinarySharesNoParValuePerShareMember" xlink:label="AmericanDepositarySharesEachRepresentingTwenty20OrdinarySharesNoParValuePerShareMember" xlink:title="AmericanDepositarySharesEachRepresentingTwenty20OrdinarySharesNoParValuePerShareMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ClassOfStockDomain" xlink:to="AmericanDepositarySharesEachRepresentingTwenty20OrdinarySharesNoParValuePerShareMember" xlink:title="definition: ClassOfStockDomain to AmericanDepositarySharesEachRepresentingTwenty20OrdinarySharesNoParValuePerShareMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="cmmb-20230221.xsd#cmmb_OrdinarySharesNoParValuePerShareMember" xlink:label="OrdinarySharesNoParValuePerShareMember" xlink:title="OrdinarySharesNoParValuePerShareMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ClassOfStockDomain" xlink:to="OrdinarySharesNoParValuePerShareMember" xlink:title="definition: ClassOfStockDomain to OrdinarySharesNoParValuePerShareMember" order="2.0" />
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>5
<FILENAME>cmmb-20230221_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!--Generated by Broadridge PROfile 23.1.1.5115 Broadridge-->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" />
  <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="ClassOfStockDomain" xlink:title="ClassOfStockDomain" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ClassOfStockDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ClassOfStockDomain_lbl" xml:lang="en-US" id="us-gaap_ClassOfStockDomain_lbl">Class of Stock [Domain]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ClassOfStockDomain" xlink:to="us-gaap_ClassOfStockDomain_lbl" xlink:title="label: ClassOfStockDomain to us-gaap_ClassOfStockDomain_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="StatementClassOfStockAxis" xlink:title="StatementClassOfStockAxis" />
    <link:label xlink:type="resource" xlink:label="us-gaap_StatementClassOfStockAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_StatementClassOfStockAxis_lbl" xml:lang="en-US" id="us-gaap_StatementClassOfStockAxis_lbl">Class of Stock [Axis]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StatementClassOfStockAxis" xlink:to="us-gaap_StatementClassOfStockAxis_lbl" xlink:title="label: StatementClassOfStockAxis to us-gaap_StatementClassOfStockAxis_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract" xlink:label="CoverAbstract" xlink:title="CoverAbstract" />
    <link:label xlink:type="resource" xlink:label="dei_CoverAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_CoverAbstract_lbl" xml:lang="en-US" id="dei_CoverAbstract_lbl">Cover [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CoverAbstract" xlink:to="dei_CoverAbstract_lbl" xlink:title="label: CoverAbstract to dei_CoverAbstract_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType" xlink:label="DocumentType" xlink:title="DocumentType" />
    <link:label xlink:type="resource" xlink:label="dei_DocumentType_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_DocumentType_lbl" xml:lang="en-US" id="dei_DocumentType_lbl">Document Type</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DocumentType" xlink:to="dei_DocumentType_lbl" xlink:title="label: DocumentType to dei_DocumentType_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_WrittenCommunications" xlink:label="WrittenCommunications" xlink:title="WrittenCommunications" />
    <link:label xlink:type="resource" xlink:label="dei_WrittenCommunications_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_WrittenCommunications_lbl" xml:lang="en-US" id="dei_WrittenCommunications_lbl">Written Communications</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" xlink:title="label: WrittenCommunications to dei_WrittenCommunications_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SolicitingMaterial" xlink:label="SolicitingMaterial" xlink:title="SolicitingMaterial" />
    <link:label xlink:type="resource" xlink:label="dei_SolicitingMaterial_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_SolicitingMaterial_lbl" xml:lang="en-US" id="dei_SolicitingMaterial_lbl">Soliciting Material</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" xlink:title="label: SolicitingMaterial to dei_SolicitingMaterial_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementTenderOffer" xlink:label="PreCommencementTenderOffer" xlink:title="PreCommencementTenderOffer" />
    <link:label xlink:type="resource" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_PreCommencementTenderOffer_lbl" xml:lang="en-US" id="dei_PreCommencementTenderOffer_lbl">Pre-commencement Tender Offer</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" xlink:title="label: PreCommencementTenderOffer to dei_PreCommencementTenderOffer_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="PreCommencementIssuerTenderOffer" xlink:title="PreCommencementIssuerTenderOffer" />
    <link:label xlink:type="resource" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_PreCommencementIssuerTenderOffer_lbl" xml:lang="en-US" id="dei_PreCommencementIssuerTenderOffer_lbl">Pre-commencement Issuer Tender Offer</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" xlink:title="label: PreCommencementIssuerTenderOffer to dei_PreCommencementIssuerTenderOffer_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag" xlink:label="AmendmentFlag" xlink:title="AmendmentFlag" />
    <link:label xlink:type="resource" xlink:label="dei_AmendmentFlag_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_AmendmentFlag_lbl" xml:lang="en-US" id="dei_AmendmentFlag_lbl">Amendment Flag</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xlink:title="label: AmendmentFlag to dei_AmendmentFlag_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalYearFocus" xlink:label="DocumentFiscalYearFocus" xlink:title="DocumentFiscalYearFocus" />
    <link:label xlink:type="resource" xlink:label="dei_DocumentFiscalYearFocus_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US" id="dei_DocumentFiscalYearFocus_lbl">Document Fiscal Year Focus</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl" xlink:title="label: DocumentFiscalYearFocus to dei_DocumentFiscalYearFocus_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="DocumentFiscalPeriodFocus" xlink:title="DocumentFiscalPeriodFocus" />
    <link:label xlink:type="resource" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US" id="dei_DocumentFiscalPeriodFocus_lbl">Document Fiscal Period Focus</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl" xlink:title="label: DocumentFiscalPeriodFocus to dei_DocumentFiscalPeriodFocus_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate" xlink:label="DocumentPeriodEndDate" xlink:title="DocumentPeriodEndDate" />
    <link:label xlink:type="resource" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US" id="dei_DocumentPeriodEndDate_lbl">Document Period End Date</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xlink:title="label: DocumentPeriodEndDate to dei_DocumentPeriodEndDate_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName" xlink:label="EntityRegistrantName" xlink:title="EntityRegistrantName" />
    <link:label xlink:type="resource" xlink:label="dei_EntityRegistrantName_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityRegistrantName_lbl" xml:lang="en-US" id="dei_EntityRegistrantName_lbl">Entity Registrant Name</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xlink:title="label: EntityRegistrantName to dei_EntityRegistrantName_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey" xlink:label="EntityCentralIndexKey" xlink:title="EntityCentralIndexKey" />
    <link:label xlink:type="resource" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityCentralIndexKey_lbl" xml:lang="en-US" id="dei_EntityCentralIndexKey_lbl">Entity Central Index Key</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xlink:title="label: EntityCentralIndexKey to dei_EntityCentralIndexKey_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber" xlink:label="EntityFileNumber" xlink:title="EntityFileNumber" />
    <link:label xlink:type="resource" xlink:label="dei_EntityFileNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityFileNumber_lbl" xml:lang="en-US" id="dei_EntityFileNumber_lbl">Entity File Number</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" xlink:title="label: EntityFileNumber to dei_EntityFileNumber_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber" xlink:label="EntityTaxIdentificationNumber" xlink:title="EntityTaxIdentificationNumber" />
    <link:label xlink:type="resource" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US" id="dei_EntityTaxIdentificationNumber_lbl">Entity Tax Identification Number</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" xlink:title="label: EntityTaxIdentificationNumber to dei_EntityTaxIdentificationNumber_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="EntityIncorporationStateCountryCode" xlink:title="EntityIncorporationStateCountryCode" />
    <link:label xlink:type="resource" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US" id="dei_EntityIncorporationStateCountryCode_lbl">Entity Incorporation, State or Country Code</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" xlink:title="label: EntityIncorporationStateCountryCode to dei_EntityIncorporationStateCountryCode_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany" xlink:label="EntityEmergingGrowthCompany" xlink:title="EntityEmergingGrowthCompany" />
    <link:label xlink:type="resource" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US" id="dei_EntityEmergingGrowthCompany_lbl">Entity Emerging Growth Company</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xlink:title="label: EntityEmergingGrowthCompany to dei_EntityEmergingGrowthCompany_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityExTransitionPeriod" xlink:label="EntityExTransitionPeriod" xlink:title="EntityExTransitionPeriod" />
    <link:label xlink:type="resource" xlink:label="dei_EntityExTransitionPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityExTransitionPeriod_lbl" xml:lang="en-US" id="dei_EntityExTransitionPeriod_lbl">Entity Ex Transition Period</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl" xlink:title="label: EntityExTransitionPeriod to dei_EntityExTransitionPeriod_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1" xlink:label="EntityAddressAddressLine1" xlink:title="EntityAddressAddressLine1" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US" id="dei_EntityAddressAddressLine1_lbl">Entity Address, Address Line One</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" xlink:title="label: EntityAddressAddressLine1 to dei_EntityAddressAddressLine1_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine2" xlink:label="EntityAddressAddressLine2" xlink:title="EntityAddressAddressLine2" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressAddressLine2_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressAddressLine2_lbl" xml:lang="en-US" id="dei_EntityAddressAddressLine2_lbl">Entity Address, Address Line Two</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" xlink:title="label: EntityAddressAddressLine2 to dei_EntityAddressAddressLine2_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine3" xlink:label="EntityAddressAddressLine3" xlink:title="EntityAddressAddressLine3" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressAddressLine3_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressAddressLine3_lbl" xml:lang="en-US" id="dei_EntityAddressAddressLine3_lbl">Entity Address, Address Line Three</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressAddressLine3" xlink:to="dei_EntityAddressAddressLine3_lbl" xlink:title="label: EntityAddressAddressLine3 to dei_EntityAddressAddressLine3_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown" xlink:label="EntityAddressCityOrTown" xlink:title="EntityAddressCityOrTown" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US" id="dei_EntityAddressCityOrTown_lbl">Entity Address, City or Town</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" xlink:title="label: EntityAddressCityOrTown to dei_EntityAddressCityOrTown_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince" xlink:label="EntityAddressStateOrProvince" xlink:title="EntityAddressStateOrProvince" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressStateOrProvince_lbl" xml:lang="en-US" id="dei_EntityAddressStateOrProvince_lbl">Entity Address, State or Province</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" xlink:title="label: EntityAddressStateOrProvince to dei_EntityAddressStateOrProvince_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCountry" xlink:label="EntityAddressCountry" xlink:title="EntityAddressCountry" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressCountry_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressCountry_lbl" xml:lang="en-US" id="dei_EntityAddressCountry_lbl">Entity Address, Country</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressCountry" xlink:to="dei_EntityAddressCountry_lbl" xlink:title="label: EntityAddressCountry to dei_EntityAddressCountry_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode" xlink:label="EntityAddressPostalZipCode" xlink:title="EntityAddressPostalZipCode" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US" id="dei_EntityAddressPostalZipCode_lbl">Entity Address, Postal Zip Code</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" xlink:title="label: EntityAddressPostalZipCode to dei_EntityAddressPostalZipCode_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode" xlink:label="CityAreaCode" xlink:title="CityAreaCode" />
    <link:label xlink:type="resource" xlink:label="dei_CityAreaCode_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_CityAreaCode_lbl" xml:lang="en-US" id="dei_CityAreaCode_lbl">City Area Code</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CityAreaCode" xlink:to="dei_CityAreaCode_lbl" xlink:title="label: CityAreaCode to dei_CityAreaCode_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber" xlink:label="LocalPhoneNumber" xlink:title="LocalPhoneNumber" />
    <link:label xlink:type="resource" xlink:label="dei_LocalPhoneNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_LocalPhoneNumber_lbl" xml:lang="en-US" id="dei_LocalPhoneNumber_lbl">Local Phone Number</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" xlink:title="label: LocalPhoneNumber to dei_LocalPhoneNumber_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityListingsTable" xlink:label="EntityListingsTable" xlink:title="EntityListingsTable" />
    <link:label xlink:type="resource" xlink:label="dei_EntityListingsTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityListingsTable_lbl" xml:lang="en-US" id="dei_EntityListingsTable_lbl">Entity Listings [Table]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityListingsTable" xlink:to="dei_EntityListingsTable_lbl" xlink:title="label: EntityListingsTable to dei_EntityListingsTable_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityListingsLineItems" xlink:label="EntityListingsLineItems" xlink:title="EntityListingsLineItems" />
    <link:label xlink:type="resource" xlink:label="dei_EntityListingsLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityListingsLineItems_lbl" xml:lang="en-US" id="dei_EntityListingsLineItems_lbl">Entity Listings [Line Items]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityListingsLineItems" xlink:to="dei_EntityListingsLineItems_lbl" xlink:title="label: EntityListingsLineItems to dei_EntityListingsLineItems_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle" xlink:label="Security12bTitle" xlink:title="Security12bTitle" />
    <link:label xlink:type="resource" xlink:label="dei_Security12bTitle_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_Security12bTitle_lbl" xml:lang="en-US" id="dei_Security12bTitle_lbl">Title of 12(b) Security</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="Security12bTitle" xlink:to="dei_Security12bTitle_lbl" xlink:title="label: Security12bTitle to dei_Security12bTitle_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_NoTradingSymbolFlag" xlink:label="NoTradingSymbolFlag" xlink:title="NoTradingSymbolFlag" />
    <link:label xlink:type="resource" xlink:label="dei_NoTradingSymbolFlag_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_NoTradingSymbolFlag_lbl" xml:lang="en-US" id="dei_NoTradingSymbolFlag_lbl">No Trading Symbol Flag</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NoTradingSymbolFlag" xlink:to="dei_NoTradingSymbolFlag_lbl" xlink:title="label: NoTradingSymbolFlag to dei_NoTradingSymbolFlag_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol" xlink:label="TradingSymbol" xlink:title="TradingSymbol" />
    <link:label xlink:type="resource" xlink:label="dei_TradingSymbol_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_TradingSymbol_lbl" xml:lang="en-US" id="dei_TradingSymbol_lbl">Trading Symbol</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TradingSymbol" xlink:to="dei_TradingSymbol_lbl" xlink:title="label: TradingSymbol to dei_TradingSymbol_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName" xlink:label="SecurityExchangeName" xlink:title="SecurityExchangeName" />
    <link:label xlink:type="resource" xlink:label="dei_SecurityExchangeName_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_SecurityExchangeName_lbl" xml:lang="en-US" id="dei_SecurityExchangeName_lbl">Security Exchange Name</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" xlink:title="label: SecurityExchangeName to dei_SecurityExchangeName_lbl" />
    <link:loc xlink:type="locator" xlink:href="cmmb-20230221.xsd#cmmb_AmericanDepositarySharesEachRepresentingTwenty20OrdinarySharesNoParValuePerShareMember" xlink:label="AmericanDepositarySharesEachRepresentingTwenty20OrdinarySharesNoParValuePerShareMember" xlink:title="AmericanDepositarySharesEachRepresentingTwenty20OrdinarySharesNoParValuePerShareMember" />
    <link:label xlink:type="resource" xlink:label="cmmb_AmericanDepositarySharesEachRepresentingTwenty20OrdinarySharesNoParValuePerShareMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="cmmb_AmericanDepositarySharesEachRepresentingTwenty20OrdinarySharesNoParValuePerShareMember_lbl1" xml:lang="en-US" id="cmmb_AmericanDepositarySharesEachRepresentingTwenty20OrdinarySharesNoParValuePerShareMember_lbl1">American Depositary Shares, each representing twenty (20) ordinary shares, no par value per share [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AmericanDepositarySharesEachRepresentingTwenty20OrdinarySharesNoParValuePerShareMember" xlink:to="cmmb_AmericanDepositarySharesEachRepresentingTwenty20OrdinarySharesNoParValuePerShareMember_lbl1" xlink:title="label: AmericanDepositarySharesEachRepresentingTwenty20OrdinarySharesNoParValuePerShareMember to cmmb_AmericanDepositarySharesEachRepresentingTwenty20OrdinarySharesNoParValuePerShareMember_lbl1" />
    <link:loc xlink:type="locator" xlink:href="cmmb-20230221.xsd#cmmb_OrdinarySharesNoParValuePerShareMember" xlink:label="OrdinarySharesNoParValuePerShareMember" xlink:title="OrdinarySharesNoParValuePerShareMember" />
    <link:label xlink:type="resource" xlink:label="cmmb_OrdinarySharesNoParValuePerShareMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="cmmb_OrdinarySharesNoParValuePerShareMember_lbl1" xml:lang="en-US" id="cmmb_OrdinarySharesNoParValuePerShareMember_lbl1">Ordinary shares, no par value per share [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OrdinarySharesNoParValuePerShareMember" xlink:to="cmmb_OrdinarySharesNoParValuePerShareMember_lbl1" xlink:title="label: OrdinarySharesNoParValuePerShareMember to cmmb_OrdinarySharesNoParValuePerShareMember_lbl1" />
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>6
<FILENAME>cmmb-20230221_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!--Generated by Broadridge PROfile 23.1.1.5115 Broadridge-->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" />
  <link:roleRef roleURI="http://chemomab.com/role/DocumentAndEntityInformation" xlink:type="simple" xlink:href="cmmb-20230221.xsd#DocumentAndEntityInformation" />
  <link:presentationLink xlink:type="extended" xlink:role="http://chemomab.com/role/DocumentAndEntityInformation">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract" xlink:label="CoverAbstract" xlink:title="CoverAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityListingsTable" xlink:label="EntityListingsTable" xlink:title="EntityListingsTable" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="StatementClassOfStockAxis" xlink:title="StatementClassOfStockAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="ClassOfStockDomain" xlink:title="ClassOfStockDomain" />
    <link:loc xlink:type="locator" xlink:href="cmmb-20230221.xsd#cmmb_AmericanDepositarySharesEachRepresentingTwenty20OrdinarySharesNoParValuePerShareMember" xlink:label="AmericanDepositarySharesEachRepresentingTwenty20OrdinarySharesNoParValuePerShareMember" xlink:title="AmericanDepositarySharesEachRepresentingTwenty20OrdinarySharesNoParValuePerShareMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ClassOfStockDomain" xlink:to="AmericanDepositarySharesEachRepresentingTwenty20OrdinarySharesNoParValuePerShareMember" xlink:title="presentation: ClassOfStockDomain to AmericanDepositarySharesEachRepresentingTwenty20OrdinarySharesNoParValuePerShareMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="cmmb-20230221.xsd#cmmb_OrdinarySharesNoParValuePerShareMember" xlink:label="OrdinarySharesNoParValuePerShareMember" xlink:title="OrdinarySharesNoParValuePerShareMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ClassOfStockDomain" xlink:to="OrdinarySharesNoParValuePerShareMember" xlink:title="presentation: ClassOfStockDomain to OrdinarySharesNoParValuePerShareMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementClassOfStockAxis" xlink:to="ClassOfStockDomain" xlink:title="presentation: StatementClassOfStockAxis to ClassOfStockDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsTable" xlink:to="StatementClassOfStockAxis" xlink:title="presentation: EntityListingsTable to StatementClassOfStockAxis" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityListingsLineItems" xlink:label="EntityListingsLineItems" xlink:title="EntityListingsLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType" xlink:label="DocumentType" xlink:title="DocumentType" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="DocumentType" xlink:title="presentation: EntityListingsLineItems to DocumentType" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag" xlink:label="AmendmentFlag" xlink:title="AmendmentFlag" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="AmendmentFlag" xlink:title="presentation: EntityListingsLineItems to AmendmentFlag" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate" xlink:label="DocumentPeriodEndDate" xlink:title="DocumentPeriodEndDate" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="DocumentPeriodEndDate" xlink:title="presentation: EntityListingsLineItems to DocumentPeriodEndDate" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName" xlink:label="EntityRegistrantName" xlink:title="EntityRegistrantName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="EntityRegistrantName" xlink:title="presentation: EntityListingsLineItems to EntityRegistrantName" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="EntityIncorporationStateCountryCode" xlink:title="EntityIncorporationStateCountryCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="EntityIncorporationStateCountryCode" xlink:title="presentation: EntityListingsLineItems to EntityIncorporationStateCountryCode" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber" xlink:label="EntityFileNumber" xlink:title="EntityFileNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="EntityFileNumber" xlink:title="presentation: EntityListingsLineItems to EntityFileNumber" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber" xlink:label="EntityTaxIdentificationNumber" xlink:title="EntityTaxIdentificationNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="EntityTaxIdentificationNumber" xlink:title="presentation: EntityListingsLineItems to EntityTaxIdentificationNumber" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1" xlink:label="EntityAddressAddressLine1" xlink:title="EntityAddressAddressLine1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="EntityAddressAddressLine1" xlink:title="presentation: EntityListingsLineItems to EntityAddressAddressLine1" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine2" xlink:label="EntityAddressAddressLine2" xlink:title="EntityAddressAddressLine2" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="EntityAddressAddressLine2" xlink:title="presentation: EntityListingsLineItems to EntityAddressAddressLine2" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine3" xlink:label="EntityAddressAddressLine3" xlink:title="EntityAddressAddressLine3" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="EntityAddressAddressLine3" xlink:title="presentation: EntityListingsLineItems to EntityAddressAddressLine3" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown" xlink:label="EntityAddressCityOrTown" xlink:title="EntityAddressCityOrTown" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="EntityAddressCityOrTown" xlink:title="presentation: EntityListingsLineItems to EntityAddressCityOrTown" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince" xlink:label="EntityAddressStateOrProvince" xlink:title="EntityAddressStateOrProvince" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="EntityAddressStateOrProvince" xlink:title="presentation: EntityListingsLineItems to EntityAddressStateOrProvince" order="11.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCountry" xlink:label="EntityAddressCountry" xlink:title="EntityAddressCountry" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="EntityAddressCountry" xlink:title="presentation: EntityListingsLineItems to EntityAddressCountry" order="12.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode" xlink:label="EntityAddressPostalZipCode" xlink:title="EntityAddressPostalZipCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="EntityAddressPostalZipCode" xlink:title="presentation: EntityListingsLineItems to EntityAddressPostalZipCode" order="13.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode" xlink:label="CityAreaCode" xlink:title="CityAreaCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="CityAreaCode" xlink:title="presentation: EntityListingsLineItems to CityAreaCode" order="14.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber" xlink:label="LocalPhoneNumber" xlink:title="LocalPhoneNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="LocalPhoneNumber" xlink:title="presentation: EntityListingsLineItems to LocalPhoneNumber" order="15.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_WrittenCommunications" xlink:label="WrittenCommunications" xlink:title="WrittenCommunications" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="WrittenCommunications" xlink:title="presentation: EntityListingsLineItems to WrittenCommunications" order="16.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SolicitingMaterial" xlink:label="SolicitingMaterial" xlink:title="SolicitingMaterial" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="SolicitingMaterial" xlink:title="presentation: EntityListingsLineItems to SolicitingMaterial" order="17.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementTenderOffer" xlink:label="PreCommencementTenderOffer" xlink:title="PreCommencementTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="PreCommencementTenderOffer" xlink:title="presentation: EntityListingsLineItems to PreCommencementTenderOffer" order="18.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="PreCommencementIssuerTenderOffer" xlink:title="PreCommencementIssuerTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="PreCommencementIssuerTenderOffer" xlink:title="presentation: EntityListingsLineItems to PreCommencementIssuerTenderOffer" order="19.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_NoTradingSymbolFlag" xlink:label="NoTradingSymbolFlag" xlink:title="NoTradingSymbolFlag" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="NoTradingSymbolFlag" xlink:title="presentation: EntityListingsLineItems to NoTradingSymbolFlag" order="20.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany" xlink:label="EntityEmergingGrowthCompany" xlink:title="EntityEmergingGrowthCompany" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="EntityEmergingGrowthCompany" xlink:title="presentation: EntityListingsLineItems to EntityEmergingGrowthCompany" order="21.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityExTransitionPeriod" xlink:label="EntityExTransitionPeriod" xlink:title="EntityExTransitionPeriod" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="EntityExTransitionPeriod" xlink:title="presentation: EntityListingsLineItems to EntityExTransitionPeriod" order="22.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalYearFocus" xlink:label="DocumentFiscalYearFocus" xlink:title="DocumentFiscalYearFocus" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="DocumentFiscalYearFocus" xlink:title="presentation: EntityListingsLineItems to DocumentFiscalYearFocus" order="23.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="DocumentFiscalPeriodFocus" xlink:title="DocumentFiscalPeriodFocus" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="DocumentFiscalPeriodFocus" xlink:title="presentation: EntityListingsLineItems to DocumentFiscalPeriodFocus" order="24.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey" xlink:label="EntityCentralIndexKey" xlink:title="EntityCentralIndexKey" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="EntityCentralIndexKey" xlink:title="presentation: EntityListingsLineItems to EntityCentralIndexKey" order="25.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle" xlink:label="Security12bTitle" xlink:title="Security12bTitle" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="Security12bTitle" xlink:title="presentation: EntityListingsLineItems to Security12bTitle" order="26.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol" xlink:label="TradingSymbol" xlink:title="TradingSymbol" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="TradingSymbol" xlink:title="presentation: EntityListingsLineItems to TradingSymbol" order="27.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName" xlink:label="SecurityExchangeName" xlink:title="SecurityExchangeName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="SecurityExchangeName" xlink:title="presentation: EntityListingsLineItems to SecurityExchangeName" order="28.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsTable" xlink:to="EntityListingsLineItems" xlink:title="presentation: EntityListingsTable to EntityListingsLineItems" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityListingsTable" xlink:title="presentation: CoverAbstract to EntityListingsTable" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>7
<FILENAME>image00002.jpg
<TEXT>
begin 644 image00002.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  8$!08%! 8&!08'!P8("A *"@D)
M"A0.#PP0%Q08&!<4%A8:'24?&ALC'!86("P@(R8G*2HI&1\M,"TH,"4H*2C_
MVP!# 0<'!PH("A,*"A,H&A8:*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H
M*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"C_P  1" #% KH# 2(  A$! Q$!_\0
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MH3P)>3+'-<WMF6.-T]L=H^I&<5XSX5_9W\5:O8I<ZA<6FCK(,K%/EY/^!*O
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M\:\.;]F37Q:[AKVF&?'^K,;XSZ;O_K5Y)XV\&:WX)U9;+7[7R9&^:&9#NCE
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M'A:2TU)];LXRUI.0;@*/]6_]X^QX_&O-Z_1L#BHXJC&I'?KZGFU(<LK!110
M6("@DDX  Y)]JZ[VW( 9., DYQP*WK/P=XANX1+;Z1<F,\@L F?P8BO4?AEX
M(CTRUCU+5H%;49!NC1QGR%^G]ZO1L5\OC>('3J.&'2:75G7##)J\CYGN_!_B
M*T3=/I%UM']Q0^/RS6&Z-'(4D5D<=588(_"OK0BLC7O#NEZY 4U*SCE..),8
M<?1NM94.))WM6AIY#EA5;W6?,->D? VX1/$%_ Q :6W!7WPW-9/CKP+=>&R;
MFW9KK32<>9_%'[-_C7/>'=6FT36K34+?EH6RR_WE_B'Y5[6(E#,<'-47>YA%
M.E-<QZC^TGI%UJ_PIU#[$C226LD=TR*,DHI^;\AS^%?$Y]J_1K2M1L];TV.[
MLI%FMIEZ$?FI'K[5X[XN_9T\/:OJ$EWHM]<:/YC;G@1!)"#_ +()!7Z9Q7R&
M$Q"H7I5-#IK4G.THGR.H)X4$D\  9R>U??\ \)=(N-!^&_A[3KU2ES#:KYB'
MJK-EBI]QG'X5Q7P]^ WAWPKJ,6I7UQ-J]_"0\1G4+%&PZ,$'?ZDUZ=KNN6&@
MVGVC4[A88B<+QEF/H!U-+%UUB9*%)7'1I^SO*1J45C>'_$FF>((7DTJY$OEG
M#J5*LOID'FMFN"<)4Y<LU9FZ:>J"BBBI&%%%% !1110!Y#^U-<-!\)+M$)'G
M74$9QZ;LG^5?/G[.-HMW\8=$W@%81--SV(C;'ZXKZ*_:<L6O/A#J;(N3;2PW
M!XZ!7&?YU\V? #44TWXO>'Y93M261[?\9$91^I%>KA?]UG;S.2K_ !(GW32T
ME+7E'6%%%% !1110!F^)?^1=U7_KTE_] -?G+&C2.L<8R[L%4>I)P*_1KQ+_
M ,B[JO\ UZ2_^@&OST\. 'Q#I8(R#=Q<'_?%>IEKLILY,3NC[Q^&?A*U\&>#
M[#2K:,"8('N9"!NDE(^8D]_0>P%=6!1BEQ7F2DY.[.I))61SWCSPW:>*_"FI
M:1?(K)<1-L8C)C<#*L/<&O@;0[V;0O$5C> F.>QNTD)!Z%6&[],U^C$@_=M]
M#7YOZW_R%-1_Z^)/_0C7J9<VXR@SFQ.C3/T=AD$D22#HZAOS%?,G[77BR22]
MTWPK;2$0QK]LNP#]YCD(I^G+?B*^E]/_ .0?:_\ 7)?Y"OAGX\7K7WQ<\2.Y
MW>5.(!]$4 5A@*:G6N^A=>34-#T?]E?P%;ZG<7'BO5H!-':R>38HXRID'+2>
M^,X'H<U]3 =Z^-_A[\<[KP7X3L]#M-!M;A+?<QF:9E+EB221CWKI/^&G]3_Z
M%NS_ / AO\*TQ.&KUJCE;0FG5A!6/J;'%8'C?PQ8>+O#=YI&J1AHIU(1\<Q/
M_"ZGL0:^>/\ AI_4_P#H6[/_ ,"&_P *#^T_J?\ T+=G_P"!+?X5BL%7B[I%
M.M3>ESQ2&74?!/C(2*QCU+1[L@XXR4."/H1G\#7Z!Z+J$6JZ/8ZA;?ZFZA2=
M/HR@_P!:_/OQKKY\4>*-1UIK9+5KV3S6A1LA3@ \U]H_ *X>Y^$/AIY#EU@*
M$^NUV _05TYA!\D9M:]3/#RU:/#/VOO^1WT7_KP/_H9I?V3_  C;ZKX@O_$%
M]&)$TP+'; C($S DM]0/_0J3]K[_ )'?1O\ KP/_ *&:[K]C\#_A!=9..?[3
M(_\ (4=5*;C@U825ZSN>\*,4DB[N#^5.%+C->0CL/A'XZ>'8/#'Q.U:SLD$=
MI,5NX448"AQD@?0YKU?]D?PI!+;ZEXINHP\ZR?8[5B,[, %R/?D#/IFN,_:L
M_P"2JG_KQA_K7LW[*0_XM2O_ %_3?^RUZ]>;^J1\SCA%>U9['MJ.>&.:%XIE
M5XY 5=6&0P/4$>E2TC#(KR#L/SY^)F@IX:\>:YI$(*P6]PWDCTC;E?T-?9_P
M3U&35/A3X;N9SF3[*(R?]PE1^@%?*7[1'_)8O$'UB_\ 1:U]/_L\_P#)'?#G
M_7)__1C5ZN,UP\),Y*&E1HR_VDO&$OA;P"UO8R&/4-5?[+&P.&1,?.P]\<?C
M7S#\(_!+^//&=MI>6CL8U\Z\E7JL0.,#W)P!]<UZ1^V!>M+XPT2RW?)#9-)M
M]V?_  6NH_8[TV-?#_B#5, S2W:VV>X"(&Q_X_\ I13?L,+SQW82]^KRL]YT
M72;+1=.M[#3+>.VLK=-D<4:X"BK])BEKRKMZLZQI'S9S7S/^T[\-+:UMF\8:
M) (B) NHPQC"G=P)<=CG /US7TS6/XOTV+5_"VL6$XS'<VDL9S[J>:UH572F
MI(BI%2C8^4_V7_&$NB>.!H<\A^P:P-@4GA)P,JP^H!'Y5]AU^<WA6[DL?$>C
MW<3%7ANX9 <XZ.*_1A#N ;UYKKS&"C44EU,L,[QL?G'KO&MZG_U]S?\ HQJ^
MV_@7X0@\*?#W3D5 +Z^C6[NY,<NSC('T (&*^)M9_P"1@U >M[*/_(AK]$]+
M18],M$7[JPH!]-HK;,)-0C%$8=7DV6<<5QOQ:\-6_B?X>ZQI]PH:18&G@<CE
M)$!92/RQ^-=G5#73_P 2/4?^O:3_ -!->7!N,DT=4E='YQ1J[LJ(,RN0JCU)
M./YU^@7PU\+6OA'P;IVDVB!62,/.V.9)6 +,??/Z 5\$Z)_R'M.'K>1?^C!7
MZ/UZ>93?NQ.;#+=B8XKS/]H?P[#KWPOU:1E!N=.3[; Y'*E.6_ KG]*]-QBN
M=^) !^'_ (D!&1_9\_!_W#7FTY.,TT=$E>-F?%GP2U!]-^*WAJ>)BH>Z$+X/
M57!4C]17WH:_/;X;?\C_ .&?^PA!_P"ABOT*KNS.W/%^1AA7[K/DC]K/Q&]_
MXRLM"C<_9M-@$LBCO+(,Y_!<?F:ZS]E#P3##I4_BZ]C#75PS6]GD?ZN,<,P]
MV/'T'O7C'QTN'G^+'BAI,Y6Y,8SUPJ@#]*^P?@[;1VOPN\,Q1?<%E&?Q/)_4
MUI7?LL-&,>HJ?O5&V=B!@"EHHKRCJ U@^-?#=EXM\-WNCZG&&AN$(5L<QO\
MPN/0@UO4TBA-Q=T#5U8_.'6M-N-&UB^TR]7;<V<S02#W4X_+O7VS^SO_ ,D9
M\-?]<Y?_ $<]?,G[1EM':_&#7!"NT2"*5O=F09-?3?[._P#R1GPU_P!<Y?\
MT<]>KCI<U"$GU.2@N6I)'HC_ '&^E?F]J7_(3N_^N[_^A&OTA?[C?2OS@OHS
M+J]Q$#CS+ADSZ9?%+*W;F?H/$]#ZD_9A^'5OI^A1>+-4A634KT$VF\9\F+IN
M'NWKZ5[X%&,52T*TCL-%L+2!0L4$$<:J.@ 4"K]>?5J.I-R9T0BHJR$V^O->
M??&7X>6GCSPM-$(U76+9"]E<8P0W783_ '6Z8_&O0J0]*F,G"2DAM*2LS\Z_
M#.LWGA;Q-8ZM:[X[JQG#LIX) .'4CW&17Z"Z=?6^H:?:WL$H\JYB69/F_A8
MC^=?#'QHTY-+^*GB6VA4+&;HRJ!_M@,?U)KH=$^*M[IVBV%DMX56VMXX0,'@
M*H']*]C$4'B(QFNQPPGR-H^TIHHYHW21%=&&&5AD$5YUKWPITV]E:72[A[!F
M.3'C?'^ ZBO2:*\S#XJMAGS4I6.V4(RW/&8OA!>&3$NK6X3U2%B?U-=GX6\
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MS]@TO*PDCAYR,<?[HR?J17USWKJS&HI5%%=#+#1:C<_.36/^1AO_ /K]E_\
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M-&: %HI,T9H 6BBDS0 M%&:0G% "T4F:6@ HHI,T +11FDS[4 +129YQ2YH
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HO#)&#112B]2C4\-:(FD1S2/<275W=-YDT\@P6/T["MNBBDW=W8S_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>8
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140676385300048">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Document and Entity Information<br></strong></div></th>
<th class="th"><div>Feb. 21, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityListingsLineItems', window );"><strong>Entity Listings [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Feb. 21,  2023<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">Chemomab Therapeutics Ltd.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">L3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-38807<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">00-0000000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">Kiryat Atidim, Building 7<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Tel Aviv<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCountry', window );">Entity Address, Country</a></td>
<td class="text">IL<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">6158002<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">972<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">77-331-0156<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityExTransitionPeriod', window );">Entity Ex Transition Period</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001534248<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=cmmb_AmericanDepositarySharesEachRepresentingTwenty20OrdinarySharesNoParValuePerShareMember', window );">American Depositary Shares, each representing twenty (20) ordinary shares, no par value per share [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityListingsLineItems', window );"><strong>Entity Listings [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">American Depositary Shares, each representing twenty (20) ordinary shares, no par value per share<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">CMMB<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=cmmb_OrdinarySharesNoParValuePerShareMember', window );">Ordinary shares, no par value per share [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityListingsLineItems', window );"><strong>Entity Listings [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Ordinary shares, no par value per share<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">N/A<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCountry">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>ISO 3166-1 alpha-2 country code.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCountry</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:countryCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityExTransitionPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 7A<br> -Section B<br> -Subsection 2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityExTransitionPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityListingsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityListingsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=cmmb_AmericanDepositarySharesEachRepresentingTwenty20OrdinarySharesNoParValuePerShareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=cmmb_AmericanDepositarySharesEachRepresentingTwenty20OrdinarySharesNoParValuePerShareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=cmmb_OrdinarySharesNoParValuePerShareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=cmmb_OrdinarySharesNoParValuePerShareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>9
<FILENAME>form8k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:cmmb="http://chemomab.com/20230221"
  xmlns:dei="http://xbrl.sec.gov/dei/2022"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:us-gaap="http://fasb.org/us-gaap/2022"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="cmmb-20230221.xsd" xlink:type="simple"/>
    <context id="c20230221to20230221">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534248</identifier>
        </entity>
        <period>
            <startDate>2023-02-21</startDate>
            <endDate>2023-02-21</endDate>
        </period>
    </context>
    <context id="c20230221to20230221_StatementClassOfStockAxis_AmericanDepositarySharesEachRepresentingTwenty20OrdinarySharesNoParValuePerShareMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534248</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">cmmb:AmericanDepositarySharesEachRepresentingTwenty20OrdinarySharesNoParValuePerShareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-02-21</startDate>
            <endDate>2023-02-21</endDate>
        </period>
    </context>
    <context id="c20230221to20230221_StatementClassOfStockAxis_OrdinarySharesNoParValuePerShareMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534248</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">cmmb:OrdinarySharesNoParValuePerShareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-02-21</startDate>
            <endDate>2023-02-21</endDate>
        </period>
    </context>
    <dei:AmendmentFlag
      contextRef="c20230221to20230221"
      id="Fact_c4648d413a80429490b83737684960a3">false</dei:AmendmentFlag>
    <dei:EntityTaxIdentificationNumber
      contextRef="c20230221to20230221"
      id="Fact_827b499388894d2983d2699b4fac3458">00-0000000</dei:EntityTaxIdentificationNumber>
    <dei:EntityCentralIndexKey
      contextRef="c20230221to20230221"
      id="Fact_bb5eac91d82c47d694f161e9a8eda0ed">0001534248</dei:EntityCentralIndexKey>
    <dei:SecurityExchangeName
      contextRef="c20230221to20230221_StatementClassOfStockAxis_OrdinarySharesNoParValuePerShareMember"
      id="Fact_7800ee96276548b596341b580ba682e4">NASDAQ</dei:SecurityExchangeName>
    <dei:SecurityExchangeName
      contextRef="c20230221to20230221_StatementClassOfStockAxis_AmericanDepositarySharesEachRepresentingTwenty20OrdinarySharesNoParValuePerShareMember"
      id="Fact_6d5d9dde38ce41a79ef18960f5e679b6">NASDAQ</dei:SecurityExchangeName>
    <dei:DocumentType
      contextRef="c20230221to20230221"
      id="Fact_1e8d67a5e319479a96041d8c4f7e3915">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate
      contextRef="c20230221to20230221"
      id="Fact_097c3bd6996d46e2bd4575c8433d9ffd">2023-02-21</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName
      contextRef="c20230221to20230221"
      id="Fact_54f7699f403b4b8da0f3061dbb621ab8">Chemomab Therapeutics Ltd.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="c20230221to20230221"
      id="Fact_ed7f83e55f0a4b08beddae26671ea988">L3</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber
      contextRef="c20230221to20230221"
      id="Fact_23f534d54203453daaea000a94b759db">001-38807</dei:EntityFileNumber>
    <dei:EntityAddressAddressLine1
      contextRef="c20230221to20230221"
      id="Fact_e24b9d3f80794d4685c212a8f19bc425">Kiryat Atidim, Building 7</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown
      contextRef="c20230221to20230221"
      id="Fact_4fa2b9620e824a57b1f54dd90922a682">Tel Aviv</dei:EntityAddressCityOrTown>
    <dei:EntityAddressCountry
      contextRef="c20230221to20230221"
      id="Fact_b9d79dd8c8ac402da729318d023d8bec">IL</dei:EntityAddressCountry>
    <dei:EntityAddressPostalZipCode
      contextRef="c20230221to20230221"
      id="Fact_7d3c117f227b4ad7b829a6bd78c06980">6158002</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="c20230221to20230221"
      id="Fact_056db533a90749b29f8b400205334538">972</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="c20230221to20230221"
      id="Fact_a465d30b3ba54a55af9eec32f997a7b4">77-331-0156</dei:LocalPhoneNumber>
    <dei:WrittenCommunications
      contextRef="c20230221to20230221"
      id="Fact_58591e2e1f2443529562a6b7d3838234">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial
      contextRef="c20230221to20230221"
      id="Fact_34813f63dc0844ef81c013044741f24c">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer
      contextRef="c20230221to20230221"
      id="Fact_c93b00f1407c48d2abcfa1faa8eb2967">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer
      contextRef="c20230221to20230221"
      id="Fact_ee53ffb1d4404dd9bf8384d2237b75eb">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle
      contextRef="c20230221to20230221_StatementClassOfStockAxis_AmericanDepositarySharesEachRepresentingTwenty20OrdinarySharesNoParValuePerShareMember"
      id="Fact_b123c56576e3485d98bde4754511ff63">American Depositary Shares, each representing twenty (20) ordinary shares, no par value per share</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="c20230221to20230221_StatementClassOfStockAxis_AmericanDepositarySharesEachRepresentingTwenty20OrdinarySharesNoParValuePerShareMember"
      id="Fact_efc8b1a62843452ea835025b22e31abb">CMMB</dei:TradingSymbol>
    <dei:Security12bTitle
      contextRef="c20230221to20230221_StatementClassOfStockAxis_OrdinarySharesNoParValuePerShareMember"
      id="Fact_adcba5d2ba7c41fa96ede1c9ee9b9160">Ordinary shares, no par value per share</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="c20230221to20230221_StatementClassOfStockAxis_OrdinarySharesNoParValuePerShareMember"
      id="Fact_e57ed6f5b2144c9b95a26c319b8d02b2">N/A</dei:TradingSymbol>
    <dei:EntityEmergingGrowthCompany
      contextRef="c20230221to20230221"
      id="Fact_dd30d57e27ef4063b7ff9d2b9c5d7da4">true</dei:EntityEmergingGrowthCompany>
    <dei:EntityExTransitionPeriod
      contextRef="c20230221to20230221"
      id="Fact_4060debb196f400b9b60e23eaa2c782f">false</dei:EntityExTransitionPeriod>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>10
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M;+-, _A]+81^.3'O)\O7RZ-_ %!+ P04    " "I.%56GZ ;\+$"  #B#
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M#ZP+V.Q _G@>F*FX3YI"5S%NV G&D3S'$)C%^(QF&5*=##[Q_F"G)$WS/(X
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MTZ(=I7\=Q_:0T^FO8R*T>EOH^7%H5 J.W&,EC'%BM/XU@LD/['X 4$L#!!0
M   ( *DX558<.&7J/P$  #P"   /    >&PO=V]R:V)O;VLN>&ULC5'+;L)
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MPNZ_/[&\UDX:?^:+X3]>?P%02P$"% ,4    " "I.%56!T%-8H$   "Q
M$               @ $     9&]C4')O<',O87!P+GAM;%!+ 0(4 Q0    (
M *DX559,"4CE[@   "L"   1              "  :\   !D;V-0<F]P<R]C
M;W)E+GAM;%!+ 0(4 Q0    ( *DX55:97)PC$ 8  )PG   3
M  "  <P!  !X;"]T:&5M92]T:&5M93$N>&UL4$L! A0#%     @ J3A55K"A
M"\[_!   :A8  !@              ("!#0@  'AL+W=O<FMS:&5E=',O<VAE
M970Q+GAM;%!+ 0(4 Q0    ( *DX55:?H!OPL0(  .(,   -
M  "  4(-  !X;"]S='EL97,N>&UL4$L! A0#%     @ J3A55I>*NQS
M$P(   L              ( !'A   %]R96QS+RYR96QS4$L! A0#%     @
MJ3A55APX9>H_ 0  / (   \              ( !!Q$  'AL+W=O<FMB;V]K
M+GAM;%!+ 0(4 Q0    ( *DX558D'INBK0   /@!   :              "
M 7,2  !X;"]?<F5L<R]W;W)K8F]O:RYX;6PN<F5L<U!+ 0(4 Q0    ( *DX
M559ED'F2&0$  ,\#   3              "  5@3  !;0V]N=&5N=%]4>7!E
<<UTN>&UL4$L%!@     )  D /@(  *(4      $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.22.4</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>3</ContextCount>
  <ElementCount>23</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>2</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="form8k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>000100 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://chemomab.com/role/DocumentAndEntityInformation</Role>
      <ShortName>Document and Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <Logs>
    <Log type="Warning">[ix-0514-Hidden-Fact-Eligible-For-Transform] WARN: 2 fact(s) appearing in ix:hidden were eligible for transformation: dei:SecurityExchangeName -  form8k.htm 11</Log>
  </Logs>
  <InputFiles>
    <File doctype="8-K" original="form8k.htm">form8k.htm</File>
    <File>cmmb-20230221.xsd</File>
    <File>cmmb-20230221_def.xml</File>
    <File>cmmb-20230221_lab.xml</File>
    <File>cmmb-20230221_pre.xml</File>
    <File>exhibit_99-1.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="26">http://xbrl.sec.gov/dei/2022</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>16
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "form8k.htm": {
   "axisCustom": 0,
   "axisStandard": 1,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2022": 26
   },
   "contextCount": 3,
   "dts": {
    "definitionLink": {
     "local": [
      "cmmb-20230221_def.xml"
     ]
    },
    "inline": {
     "local": [
      "form8k.htm"
     ]
    },
    "labelLink": {
     "local": [
      "cmmb-20230221_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "cmmb-20230221_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "cmmb-20230221.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2004/ref-2004-08-10.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-roles-2022.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd",
      "https://xbrl.sec.gov/country/2022/country-2022.xsd",
      "https://xbrl.sec.gov/currency/2022/currency-2022.xsd",
      "https://xbrl.sec.gov/dei/2022/dei-2022.xsd",
      "https://xbrl.sec.gov/exch/2022/exch-2022.xsd",
      "https://xbrl.sec.gov/naics/2022/naics-2022.xsd",
      "https://xbrl.sec.gov/sic/2022/sic-2022.xsd",
      "https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd"
     ]
    }
   },
   "elementCount": 36,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2022": 5,
    "total": 5
   },
   "keyCustom": 0,
   "keyStandard": 23,
   "memberCustom": 2,
   "memberStandard": 0,
   "nsprefix": "cmmb",
   "nsuri": "http://chemomab.com/20230221",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "b",
       "p",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "form8k.htm",
      "contextRef": "c20230221to20230221",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "000100 - Document - Document and Entity Information",
     "menuCat": "Cover",
     "order": "1",
     "role": "http://chemomab.com/role/DocumentAndEntityInformation",
     "shortName": "Document and Entity Information",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "b",
       "p",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "form8k.htm",
      "contextRef": "c20230221to20230221",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 2,
   "tag": {
    "cmmb_AmericanDepositarySharesEachRepresentingTwenty20OrdinarySharesNoParValuePerShareMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "American Depositary Shares, each representing twenty (20) ordinary shares, no par value per share [Member]"
       }
      }
     },
     "localname": "AmericanDepositarySharesEachRepresentingTwenty20OrdinarySharesNoParValuePerShareMember",
     "nsuri": "http://chemomab.com/20230221",
     "presentation": [
      "http://chemomab.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "domainItemType"
    },
    "cmmb_OrdinarySharesNoParValuePerShareMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Ordinary shares, no par value per share [Member]"
       }
      }
     },
     "localname": "OrdinarySharesNoParValuePerShareMember",
     "nsuri": "http://chemomab.com/20230221",
     "presentation": [
      "http://chemomab.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://chemomab.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://chemomab.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "xbrltype": "stringItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://chemomab.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://chemomab.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://chemomab.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://chemomab.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://chemomab.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine2": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 2 such as Street or Suite number",
        "label": "Entity Address, Address Line Two"
       }
      }
     },
     "localname": "EntityAddressAddressLine2",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://chemomab.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine3": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 3 such as an Office Park",
        "label": "Entity Address, Address Line Three"
       }
      }
     },
     "localname": "EntityAddressAddressLine3",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://chemomab.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://chemomab.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCountry": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "ISO 3166-1 alpha-2 country code.",
        "label": "Entity Address, Country"
       }
      }
     },
     "localname": "EntityAddressCountry",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://chemomab.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "countryCodeItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://chemomab.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://chemomab.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://chemomab.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://chemomab.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityExTransitionPeriod": {
     "auth_ref": [
      "r7"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.",
        "label": "Entity Ex Transition Period"
       }
      }
     },
     "localname": "EntityExTransitionPeriod",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://chemomab.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://chemomab.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://chemomab.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityListingsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Entity Listings [Line Items]"
       }
      }
     },
     "localname": "EntityListingsLineItems",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://chemomab.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_EntityListingsTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Container for exchange listing information for an entity",
        "label": "Entity Listings [Table]"
       }
      }
     },
     "localname": "EntityListingsTable",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://chemomab.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://chemomab.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://chemomab.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://chemomab.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_NoTradingSymbolFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a security having no trading symbol.",
        "label": "No Trading Symbol Flag"
       }
      }
     },
     "localname": "NoTradingSymbolFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://chemomab.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "trueItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre-commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://chemomab.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre-commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://chemomab.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://chemomab.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://chemomab.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://chemomab.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://chemomab.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://chemomab.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "us-gaap_ClassOfStockDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of Stock [Domain]"
       }
      }
     },
     "localname": "ClassOfStockDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://chemomab.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_StatementClassOfStockAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of Stock [Axis]"
       }
      }
     },
     "localname": "StatementClassOfStockAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://chemomab.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "stringItemType"
    }
   },
   "unitCount": 0
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r1": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r2": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r3": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r4": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r5": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r6": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r7": {
   "Name": "Securities Act",
   "Number": "7A",
   "Publisher": "SEC",
   "Section": "B",
   "Subsection": "2",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  }
 },
 "version": "2.2"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>17
<FILENAME>0001178913-23-000679-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001178913-23-000679-xbrl.zip
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MW5HPMKSJ=M?K=6?=[V R[[H7%[WN/U\>QMX"AJ"-(LI Y,&6P_%7-#[X@#W
M8I]3IV^F)) &^MU]7X4(\5=;PMKB4+OGMON]SH;ZK<1%T6S0B81O<OB$4^_R
M\K(;M^ZAW! J,;VGS:/G.+OX$1S 9SASQ.>?S\/"LR^[ M&-('L 4QCP+N/3
MV78)KUL4A<L RF,+ F=Z.P$A>S,B.I<B.KUW(CIO7BQWCW%O+L0TP0P$I_$S
MMI?W-=?-\4X_GBJT92X_GC+*?)##5XARJIOCG1Y!@K!_%_GG=SS;U:F<'S-
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MX$3/TK[OYN+$L_%-O"-PUR)^B7?J??@?4$L#!!0    ( *DX55:Q CELW1(
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MW&Y@5<KB@W11 MXJZX+G0T/>WU#+DXI6A::83$=4%BMAVB%D6,][*RAX6)]
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M=(%[6N#FV:&-&AB\*S)\"V"K54*C(F0RSL0/-+C]VN"N-Y$(>U;%Z "QC'0
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M'+(I6L;[X\-_&;A=FZ:_!)VWY_BK.=/ I3ME@7+>G!K@(PO^^$2XTAQR\)W
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M0\#G?4W(QC>!=+\F9.,[1+[*UX2L"63+]W;4K\Z>TA"77X3OH?D?4$L#!!0
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MI&O6#5,1R<]F@AL6F&,8K<!4#6(2EV(U,%1;HX38NH;).I&M3A$ 1K<]QO&
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M8BTR,#(S,#(R,5]P<F4N>&UL4$L! A0#%     @ J3A55K$".6S=$@  D$8
M !               ( !H!T  &5X:&EB:71?.3DM,2YH=&U02P$"% ,4
M" "I.%56,_<I(=,3  "3CP  "@              @ &K,   9F]R;3AK+FAT
7;5!+!08     !@ & 'X!  "F1      !

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
